NEXTGEN HEALTHCARE, INC. - Quarter Report: 2010 September (Form 10-Q)

e10vq

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2010


o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-12537

QUALITY SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


California (State or other jurisdiction of incorporation or organization)		95-2888568 (IRS Employer Identification No.)

18111 Von Karman Avenue, Suite 600, Irvine, California (Address of principal executive offices)		92612 (Zip Code)

(949) 255-2600
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer þ	Accelerated filer o	Non-accelerated filer o (Do not check if a smaller reporting company)	Small reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date.

28,956,944 shares of Common Stock, $0.01 par value, outstanding as of October 29, 2010

QUALITY SYSTEMS, INC.

FORM 10-Q
For the Quarterly Period Ended September 30, 2010

INDEX


Item	Page

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements
Consolidated Balance Sheets as of September 30, 2010 and March 31, 2010 (unaudited)		3
Consolidated Statements of Income for the three and six months ended September 30, 2010 and 2009 (unaudited)		4
Consolidated Statements of Cash Flows for the six months ended September 30, 2010 and 2009 (unaudited)		5
Notes to Consolidated Financial Statements (unaudited)		7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		23
Item 3. Quantitative and Qualitative Disclosures About Market Risk		40
Item 4. Controls and Procedures		40

Part II. OTHER INFORMATION

Item 1. Legal Proceedings		41
Item 1A. Risk Factors		41
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		41
Item 3. Defaults Upon Senior Securities		41
Item 4. (Removed and Reserved)		41
Item 5. Other Information		41
Item 6. Exhibits		42
Signatures		43
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

QUALITY SYSTEMS, INC.

CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)


	September 30,		March 31,
	2010		2010
ASSETS
Current assets:
Cash and cash equivalents	$	106,852	$	84,611
Restricted cash		2,114		2,339
Marketable securities		—		7,158
Accounts receivable, net		112,506		107,458
Inventories, net		1,483		1,340
Income taxes receivable		177		2,953
Deferred income taxes, net		5,470		5,678
Other current assets		8,086		8,684


Total current assets		236,688		220,221

Equipment and improvements, net		8,728		8,432
Capitalized software costs, net		13,799		11,546
Intangibles, net		18,550		20,145
Goodwill		46,189		46,189
Other assets		4,494		3,647


Total assets	$	328,448	$	310,180


LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	5,972	$	3,342
Deferred revenue		65,737		64,109
Accrued compensation and related benefits		6,988		8,951
Dividends payable		8,686		8,664
Other current liabilities		19,026		16,220


Total current liabilities		106,409		101,286

Deferred revenue, net of current		797		474
Deferred income taxes, net		10,254		10,859
Deferred compensation		2,178		1,883
Other noncurrent liabilities		7,354		7,389


Total liabilities		126,992		121,891

Commitments and contingencies (Note 13)

Shareholders’ equity:
Common stock $0.01 par value; authorized 50,000 shares; issued and outstanding 28,956 and 28,879 shares at September 30, 2010 and March 31, 2010, respectively		290		289
Additional paid-in capital		127,274		122,271
Retained earnings		73,892		65,729


Total shareholders’ equity		201,456		188,289


Total liabilities and shareholders’ equity	$	328,448	$	310,180

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)


	Three Months Ended September 30,				Six Months Ended September 30,
	2010		2009		2010		2009
Revenues:
Software, hardware and supplies	$	20,375	$	22,856	$	45,131	$	40,632
Implementation and training services		4,499		3,380		8,807		6,837


System sales		24,874		26,236		53,938		47,469

Maintenance		27,529		21,475		53,065		43,115
Electronic data interchange services		10,142		8,796		19,906		16,958
Revenue cycle management and related services		11,175		8,888		21,947		17,880
Other services		7,737		6,303		15,528		12,914


Maintenance, EDI, RCM and other services		56,583		45,462		110,446		90,867


Total revenues		81,457		71,698		164,384		138,336


Cost of revenue:
Software, hardware and supplies		4,696		3,737		10,908		6,441
Implementation and training services		3,475		3,296		6,465		6,177


Total cost of system sales		8,171		7,033		17,373		12,618

Maintenance		3,238		3,255		6,692		6,280
Electronic data interchange services		6,773		6,164		13,482		12,054
Revenue cycle management and related services		8,222		6,856		16,367		13,378
Other services		3,724		5,003		8,073		9,870


Total cost of maintenance, EDI, RCM and other services		21,957		21,278		44,614		41,582


Total cost of revenue		30,128		28,311		61,987		54,200


Gross profit		51,329		43,387		102,397		84,136

Operating expenses:
Selling, general and administrative		24,829		20,061		51,067		40,154
Research and development costs		5,232		4,346		10,688		8,323
Amortization of acquired intangible assets		445		367		792		724


Total operating expenses		30,506		24,774		62,547		49,201


Income from operations		20,823		18,613		39,850		34,935

Interest income		129		59		189		137
Other income, net		65		—		59		58


Income before provision for income taxes		21,017		18,672		40,098		35,130
Provision for income taxes		7,587		6,852		14,576		12,964


Net income	$	13,430	$	11,820	$	25,522	$	22,166


Net income per share:
Basic	$	0.46	$	0.41	$	0.88	$	0.78
Diluted	$	0.46	$	0.41	$	0.88	$	0.77

Weighted-average shares outstanding:
Basic		28,935		28,597		28,915		28,545
Diluted		29,078		28,742		29,066		28,717

Dividends declared per common share	$	0.30	$	0.30	$	0.60	$	0.60

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)


	Six Months Ended September 30,
	2010			2009
Cash flows from operating activities:
Net income	$	25,522		$	22,166
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		1,970			1,798
Amortization of capitalized software costs		3,453			2,851
Amortization of other intangibles		1,595			725
Provision for bad debts		1,986			1,803
Share-based compensation		1,864			1,319
Deferred income tax benefit		(397	)		(631	)
Tax benefit associated with stock options		319			1,057
Excess tax benefit from share-based compensation		(319	)		(1,057	)
Changes in assets and liabilities, net of amounts acquired:
Accounts receivable		(7,034	)		(8,816	)
Inventories		(143	)		(120	)
Income taxes receivable		2,776			120
Other current assets		281			(1,723	)
Other assets		(847	)		(324	)
Accounts payable		2,630			558
Deferred revenue		1,951			1,110
Accrued compensation and related benefits		(1,963	)		(1,551	)
Other current liabilities		2,806			3,762
Deferred compensation		295			(164	)
Other noncurrent liabilities		(35	)		—


Net cash provided by operating activities		36,710			22,883


Cash flows from investing activities:
Additions to capitalized software costs		(5,706	)		(2,945	)
Additions to equipment and improvements		(2,266	)		(3,068	)
Proceeds from sale of marketable securities		7,700			—
Purchase of Sphere		—			(300	)


Net cash used in investing activities		(272	)		(6,313	)


Cash flows from financing activities:
Excess tax benefit from share-based compensation		319			1,057
Proceeds from exercise of stock options		2,821			4,712
Dividends paid		(17,337	)		(17,090	)


Net cash used in financing activities		(14,197	)		(11,321	)


Net increase in cash and cash equivalents		22,241			5,249

Cash and cash equivalents at beginning of period		84,611			70,180


Cash and cash equivalents at end of period	$	106,852		$	75,429

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued)
(In thousands)
(Unaudited)


	Six Months Ended September 30,
	2010		2009
Supplemental disclosures of cash flow information:

Cash paid during the period for income taxes, net of refunds	$	11,882	$	12,363


Non-cash investing activities:

Effective August 12, 2009, the Company acquired Sphere in a transaction summarized as follows:
Fair value of net assets acquired	$	—	$	1,453
Cash paid		—		(300	)
Fair value of contingent consideration		—		(1,074	)


Liabilities assumed	$	—	$	79

The accompanying notes are an integral part of these consolidated financial statements.

QUALITY SYSTEMS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except shares and per share data)
(Unaudited)

1. Summary of Significant Accounting Policies

Principles of Consolidation. The consolidated financial statements include the accounts of Quality Systems, Inc. and its wholly-owned subsidiaries, which consists of NextGen Healthcare Information Systems (“NextGen”), Lackland Acquisition II, LLC dba Healthcare Strategic Initiatives (“HSI”), Practice Management Partners, Inc. (“PMP”), NextGen Inpatient Solutions, LLC (“Sphere”), and Opus Healthcare Solutions, Inc. (“Opus”) (collectively, the “Company”). All intercompany accounts and transactions have been eliminated.

Business Segments. The Company has prepared operating segment information in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, or ASC 280, which requires that companies disclose “operating segments” based on the manner in which management disaggregates the Company’s operations for making internal operating decisions. See Note 11.

Basis of Presentation. The accompanying unaudited consolidated financial statements as of September 30, 2010 and for the three and six months ended September 30, 2010 and 2009, have been prepared in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X, and therefore do not include all information and notes which would be presented were such consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These consolidated financial statements should be read in conjunction with the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2010. Amounts related to disclosures of March 31, 2010 balances within these interim consolidated financial statements were derived from the aforementioned Form 10-K. In the opinion of management, the accompanying consolidated financial statements reflect all adjustments which are necessary for a fair presentation of the results of operations and cash flows for the periods presented. The results of operations for such interim periods are not necessarily indicative of results of operations to be expected for the full year.

Certain prior period amounts have been reclassified to conform with fiscal year 2011 presentation.

References to amounts in the consolidated financial statement sections are in thousands, except shares and per share data, unless otherwise specified.

Revenue Recognition. The Company recognizes revenue for system sales pursuant to FASB ASC Topic 985-605, Software, Revenue Recognition, or ASC 985-605. The Company generates revenue from the sale of licensing rights to its software products directly to end-users and value-added resellers, or VARs. The Company also generates revenue from sales of hardware and third party software, implementation, training, Electronic Data Interchange (“EDI”), post-contract support (maintenance), and other services, including revenue cycle management (“RCM”), performed for customers who license its products.

A typical system contract contains multiple elements of the above items. FASB ASC Topic 985-605-25, Software, Revenue Recognition, Multiple Elements, or ASC 985-605-25, requires revenue earned on software arrangements involving multiple elements to be allocated to each element based on the relative fair values of those elements. The fair value of an element must be based on vendor-specific objective evidence (“VSOE”). The Company limits its assessment of VSOE for each element to either the price charged when the same element is sold separately or the price established by management having the relevant authority to do so, for an element not yet sold separately. VSOE calculations are updated and reviewed quarterly or annually depending on the nature of the product or service. The Company has established VSOE for the related undelivered elements based on the bell-shaped curve method. Maintenance VSOE for the Company’s largest customers is based on stated renewal rates only if the rate is determined to be substantive and falls within the Company’s customary pricing practices.

When evidence of fair value exists for the delivered and undelivered elements of a transaction, then discounts for individual elements are aggregated and the total discount is allocated to the individual elements in proportion to the elements’ fair value relative to the total contract fair value.

When evidence of fair value exists for the undelivered elements only, the residual method, provided for under ASC 985-605, is used. Under the residual method, the Company defers revenue related to the undelivered elements in a system sale based on VSOE of fair value of each of the undelivered elements, and allocates the remainder of the contract price net of all discounts to revenue recognized from the delivered elements. If VSOE of fair value of any undelivered element does not exist, all revenue is deferred until VSOE of fair value of the undelivered element is established or the element has been delivered.

The Company bills for the entire system sales contract amount upon contract execution except for maintenance which is billed separately. Amounts billed in excess of the amounts contractually due are recorded in accounts receivable as advance billings. Amounts are contractually due when services are performed or in accordance with contractually specified payment dates. Provided the fees are fixed or determinable and collection is considered probable, revenue from licensing rights and sales of hardware and third party software is generally recognized upon physical or electronic shipment and transfer of title. In certain transactions where collections risk is high, the cash basis method is used to recognize revenue. If the fee is not fixed or determinable, then the revenue recognized in each period (subject to application of other revenue recognition criteria) will be the lesser of the aggregate of amounts due and payable or the amount of the arrangement fee that would have been

recognized if the fees were being recognized using the residual method. Fees which are considered fixed or determinable at the inception of the Company’s arrangements must include the following characteristics:

§		The fee must be negotiated at the outset of an arrangement, and generally be based on the specific volume of products to be delivered without being subject to change based on variable pricing mechanisms such as the number of units copied or distributed or the expected number of users.

§		Payment terms must not be considered extended. If a significant portion of the fee is due more than 12 months after delivery or after the expiration of the license, the fee is presumed not fixed or determinable.

Revenue from implementation and training services is recognized as the corresponding services are performed. Maintenance revenue is recognized ratably over the contractual maintenance period.

Contract accounting is applied where services include significant software modification, development or customization. In such instances, the arrangement fee is accounted for in accordance with FASB ASC Topic 605-35, Revenue Recognition, Construction-Type and Production-Type Contracts, or ASC 605-35. Pursuant to ASC 605-35, the Company uses the percentage of completion method provided all of the following conditions exist:

§		the contract includes provisions that clearly specify the enforceable rights regarding goods or services to be provided and received by the parties, the consideration to be exchanged, and the manner and terms of settlement;

§		the customer can be expected to satisfy its obligations under the contract;

§		the Company can be expected to perform its contractual obligations; and

§		reliable estimates of progress towards completion can be made.

The Company measures completion using labor input hours. Costs of providing services, including services accounted for in accordance with ASC 605-35, are expensed as incurred.

If a situation occurs in which a contract is so short term that the financial statements would not vary materially from using the percentage-of-completion method or in which the Company is unable to make reliable estimates of progress of completion of the contract, the completed contract method is utilized.

Product returns are estimated in accordance with FASB ASC Topic 605-15, Revenue Recognition, Products, or ASC 605-15. The Company also ensures that the other criteria in ASC 605-15 have been met prior to recognition of revenue:

§		the price is fixed or determinable;

§		the customer is obligated to pay and there are no contingencies surrounding the obligation or the payment;

§		the customer’s obligation would not change in the event of theft or damage to the product;

§		the customer has economic substance;

§		the amount of returns can be reasonably estimated; and

§		the Company does not have significant obligations for future performance in order to bring about resale of the product by the customer.

The Company has historically offered short-term rights of return in certain sales arrangements. If the Company is able to estimate returns for these types of arrangements, revenue is recognized, net of an allowance for returns, and these arrangements are recorded in the consolidated financial statements. If the Company is unable to estimate returns for these types of arrangements, revenue is not recognized in the consolidated financial statements until the rights of return expire.

Revenue related to sales arrangements that include the right to use software stored on the Company’s hardware is accounted for under FASB ASC Topic 985-605-05, Software, Revenue Recognition, Hosting Arrangements, or ASC 985-605-05, which requires that for software licenses and related implementation services to continue to fall under ASC 985-605-05, the customer must have the contractual right to take possession of the software without incurring a significant penalty and it must be feasible for the customer to either host the software themselves or through another third party. If an arrangement is not deemed to be accounted for under ASC 985-605-05, the entire arrangement is accounted for as a service contract in accordance with ASC 985-605-25. In that instance, the entire arrangement would be recognized during the period that the hosting services are being performed.

From time to time, the Company offers future purchase discounts on its products and services as part of its sales arrangements. Pursuant to FASB ASC Topic 985-605-55, Software, Revenue Recognition, Flowchart of Revenue Recognition on Software Arrangements, or ASC 985-605-55, such discounts that are incremental to the range of discounts reflected in the pricing of the other elements of the arrangement, that are incremental to the range of discounts typically given in comparable transactions, and that are significant, are treated as an additional element of the contract to be deferred. Amounts deferred related to future purchase options are not recognized until either the customer exercises the discount offer or the offer expires.

RCM service revenue is derived from services fees, which include amounts charged for ongoing billing and other related services, and are generally billed to the customer as a percentage of total collections. The Company does not recognize revenue for services fees until these collections are made, as the services fees are not fixed or determinable until such time.

Revenue is divided into two categories, “system sales” and “maintenance, EDI, RCM and other services.” Revenue in the system sales category includes software license fees, third party hardware and software, and implementation and training services related to purchase of the Company’s software systems. Revenue in the maintenance, EDI, RCM and other services category includes maintenance, EDI, RCM services, follow on training and implementation services, annual third party license fees, hosting services and other services revenue.

Cash and Cash Equivalents. Cash and cash equivalents generally consist of cash, money market funds and short-term U.S. Treasury securities with original maturities of less than 90 days. The money market fund in which the Company holds a portion of its cash invests in only investment grade money market instruments from a variety of industries, and therefore bears relatively low market risk. The average maturity of the investments owned by the money market fund is approximately two months.

Restricted Cash. Restricted cash consists of cash which is being held by HSI acting as agent for the disbursement of certain state social services programs. The Company records an offsetting “Care Services liability” (see also Note 3) when it initially receives such cash from the government social service programs and relieves both restricted cash and the Care Services liability when amounts are disbursed. HSI earns an administrative fee which is based on a percentage of funds disbursed on behalf of certain government social service programs.

Marketable Securities and ARS Put Option Rights. Marketable securities are recorded at fair value, based on quoted market rates or valuation analysis when appropriate.

Previously, the Company held investments in tax exempt municipal Auction Rate Securities (“ARS”), which were classified as either current or non-current marketable securities depending on the liquidity and timing of expected realization of such securities. The ARS were rated by one or more national rating agencies and had contractual terms of up to 30 years, but generally had interest rate reset dates that occurred every 7, 28 or 35 days. Despite the underlying long-term maturity of ARS, such securities were priced and subsequently traded as short-term investments because of the interest rate reset feature. If there were insufficient buyers, the auction is said to “fail” and the holders were unable to liquidate the investments through auction. A failed auction did not result in a default of the debt instrument. Under their respective terms, the securities continued to accrue interest and be auctioned until the auction succeeded, the issuer called the securities or the securities matured. In February 2008, the Company began to experience failed auctions on its ARS.

The Company’s ARS were held by UBS Financial Services Inc. (“UBS”). On November 13, 2008, the Company entered into an Auction Rate Security Rights Agreement (the “Rights Agreement”) with UBS, whereby the Company accepted UBS’s offer to purchase the Company’s ARS investments at any time during the period of June 30, 2010 through July 2, 2012. As a result, the Company had obtained an asset, ARS put option rights, whereby the Company had a right to “put” the ARS back to UBS.

Prior to signing the Rights Agreement, the Company had asserted that it had the intent and ability to hold these securities until anticipated recovery and classified its ARS as held for sale securities. By accepting the Rights Agreement, the Company could no longer assert that it has the intent to hold the auction rate securities until anticipated recovery and consequently elected to reclassify its investments in ARS as trading securities, as defined by FASB ASC Topic 320, Investments — Debt and Equity Securities, or ASC 320, on the date of Company’s acceptance of the Rights Agreement. As trading securities, the ARS were carried at fair value with changes recorded through earnings.

To determine the estimated fair values of the ARS, factors including credit quality, assumptions about the likelihood of redemption, observable market data such as yields or spreads of fixed rate municipal bonds and other trading instruments issued by the same or comparable issuers, were considered. The Company had valued the ARS as the approximate midpoint between various fair values, measured as the difference between the par value of the ARS and the fair value of the securities, discounted by the credit risk of the broker and other factors such as the Company’s historical experience to sell ARS at par.

As the Company was permitted to put the ARS back to UBS at par value, the Company accounted for the ARS put option right as a separate asset that was measured at its fair value with changes recorded through earnings. The Company had valued the ARS put option right as the approximate midpoint between various fair values, measured as the difference between the par value of the ARS and the fair value of the securities, discounted by the credit risk of the broker and other factors such as the Company’s historical experience to sell ARS at par.

On June 30, 2010, the earliest date allowable under the Rights Agreement, the Company exercised its ARS put option rights and put its ARS back to UBS. The ARS were sold and settled on July 1, 2010 at 100% of the $7,700 par value.

Allowance for Doubtful Accounts. The Company provides credit terms typically ranging from thirty days to less than twelve months for most system and maintenance contract sales and generally does not require collateral. The Company performs credit evaluations of its customers and maintains reserves for estimated credit losses. Reserves for potential credit losses are determined by establishing both specific and general reserves. Specific reserves are based on management’s estimate of the probability of collection for certain troubled accounts. General reserves are established based on the Company’s historical experience of bad debt expense and the aging of the Company’s accounts receivable balances, net of deferred revenue and specifically reserved accounts. Accounts are written off as uncollectible only after the Company has expended extensive collection efforts.

Included in accounts receivable are amounts related to maintenance and services which were billed, but which had not yet been rendered as of the end of the period. Undelivered maintenance and services are included as a component of deferred revenue (see also Note 3).

Software Development Costs. Development costs incurred in the research and development of new software products and enhancements to existing software products are expensed as incurred until technological feasibility has been established. After technological feasibility is established, any additional development costs are capitalized in accordance with FASB ASC Topic 985-20, Software, Costs of Computer Software to be Sold, Leased or Marketed, or ASC 985-20. Such capitalized costs are amortized on a straight-line basis over the estimated economic life of the related product, which is typically three years. The Company provides support services on the current and prior two versions of its software. Management performs an annual review of the estimated economic life and the recoverability of such capitalized software costs. If a determination is made that capitalized amounts are not recoverable based on the estimated cash flows to be generated from the applicable software, any remaining capitalized amounts are written off.

Goodwill. Goodwill is related to NextGen and the HSI, PMP, Sphere, and Opus acquisitions, which closed on May 20, 2008, October 28, 2008, August 12, 2009, and February 10, 2010, respectively (see Notes 4 and 5). In accordance with FASB ASC Topic 350-20, Intangibles — Goodwill and Other, Goodwill, or ASC 350-20, the Company tests goodwill for impairment annually at the end of its first fiscal quarter, referred to as the annual test date. The Company will also test for impairment between annual test dates if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is performed at a reporting-unit level, which is defined as an operating segment or one level below and operating segment (referred to as a component). A component of an operating segment is a reporting unit if the component constitutes a business for which discrete financial information is available and segment management regularly reviews the operating results of that component.

The Company has determined that NextGen, HSI, and PMP each qualify as a separate reporting unit level while Sphere and Opus are aggregated as one reporting unit at which goodwill impairment testing is performed.

An impairment loss would generally be recognized when the carrying amount of the reporting unit’s net assets exceeds the estimated fair value of the reporting unit. Based on its analysis, the Company has determined that there was no risk of impairment to its goodwill as of September 30, 2010. See also Note 5.

Intangible Assets. Intangible assets consist of capitalized software costs, customer relationships, trade names and certain intellectual property. Intangible assets related to customer relationships, trade names, and software technology arose in connection with the acquisition of HSI, PMP, Sphere, and Opus. These intangible assets were recorded at fair value and are stated net of accumulated amortization. Intangible assets are amortized over their remaining estimated useful lives, ranging from 3 to 9 years. The Company’s amortization policy for intangible assets is based on the principles in FASB ASC Topic 350-30, Intangibles — Goodwill and Other, General Intangibles Other than Goodwill, or ASC 350-30, which requires that the amortization of intangible assets reflect the pattern that the economic benefits of the intangible assets are consumed.

Income Taxes. The Company accounts for income taxes in accordance with FASB ASC Topic 740, Income Taxes, or ASC 740. Income taxes are provided based on current taxable income and the future tax consequences of temporary differences between the basis of assets and liabilities for financial and tax reporting. The deferred income tax assets and liabilities represent the future state and federal tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred income taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future income taxes. At each reporting period, management assesses the realizable value of deferred tax assets based on, among other things, estimates of future taxable income, and adjusts the related valuation allowance as necessary. Management makes a number of assumptions and estimates in determining the appropriate amount of expense to record for income taxes. These assumptions and estimates consider the taxing jurisdiction in which the Company operates as well as current tax regulations. Accruals are established for estimates of tax effects for certain transactions and future projected profitability of the Company’s businesses based on management’s interpretation of existing facts and circumstances.

Self-Insurance Liabilities. Effective January 1, 2010, the Company became self-insured with respect to healthcare claims, subject to stop-loss limits. The Company accrues for estimated self-insurance costs and uninsured exposures based on claims filed and an estimate of claims incurred but not reported as of each balance sheet date. However, it is possible that recorded accruals may not be adequate to cover the future payment of claims. Adjustments, if any, to estimated accruals resulting from ultimate claim payments will be reflected in earnings during the periods in which such adjustments are determined. Periodically, the Company reevaluates the adequacy of the accruals by comparing amounts accrued on the balance sheets for anticipated losses to an updated actuarial loss forecasts and third party claim administrator loss estimates and makes adjustments to the accruals as needed. The self-insurance accrual is included in other current liabilities. If any of the factors that contribute to the overall cost of insurance claims were to change, the actual amount incurred for the self-insurance liabilities would be directly affected.

Share-Based Compensation. FASB ASC Topic 718 Compensation — Stock Compensation, or ASC 718, requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. Expected term is estimated using historical exercise experience. Volatility is estimated by using the weighted-average historical volatility of the Company’s Common Stock, which approximates expected volatility. The risk free rate is the implied yield available on the U.S Treasury zero-coupon issues with remaining terms equal to the expected term. The expected dividend yield is the average dividend rate during a period equal to the expected term of the option. Those inputs are then entered into the Black Scholes model to determine the estimated fair value. The value of the portion of the award that is ultimately expected to vest is recognized ratably as expense over the requisite service period in the Company’s consolidated statements of income.

Share-based compensation is adjusted on a quarterly basis for changes to estimated forfeitures based on a review of historical forfeiture activity. To the extent that actual forfeitures differ, or are expected to differ, from the estimate, share-based compensation expense is adjusted accordingly. The effect of the forfeiture adjustments for the three and six months ended September 30, 2010 and 2009 was not significant.

The following table shows total share-based compensation expense included in the consolidated statements of income for the three and six months ended September 30, 2010 and 2009.


	Three Months Ended September 30,						Six Months Ended September 30,
	2010			2009			2010			2009
Costs and expenses:
Cost of revenue	$	69		$	12		$	137		$	27
Research and development costs		44			20			72			37
Selling, general and administrative		686			825			1,655			1,255


Total share-based compensation		799			857			1,864			1,319

Amounts capitalized in software development costs		(1	)		(10	)		(2	)		(25	)


Amounts charged against earnings, before income tax benefit	$	798		$	847		$	1,862		$	1,294

Related income tax benefit (1)		(315	)		(273	)		(663	)		(411	)


Decrease in net income (1)	$	483		$	574		$	1,199		$	883


(1)		The prior period presentation has been changed to conform with current period presentation.

Newly Adopted Accounting Standards

In January 2010, the FASB issued Accounting Standards Update, or ASU, 2010-06, Fair Value Measurements and Disclosures (Topic 820) — Improving Disclosures about Fair Value Measurements, or ASU 2010-06, to require additional disclosures about recurring or nonrecurring fair value measurements, including significant transfers into and out of Level 1 and Level 2 fair value measurements and information on purchases, sales, issuances, and settlements on a gross basis in the reconciliation of Level 3 fair value measurements. The standard also clarifies existing disclosures about the level of disaggregation, valuation techniques and inputs to fair value measurements. The provisions of ASU 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the Level 3 reconciliation disclosures that are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. The Company adopted the provisions of ASU 2010-06 regarding Level 1 and Level 2 fair value measurements during the quarter ended June 30, 2010. As the Company did not have any transfers between Level 1 and Level 2 fair value measurement, the adoption of this standard did not have a material effect on the Company’s consolidated financial statements. The Company does not expect the future adoption of the provisions for Level 3 reconciliation to have a significant impact on its consolidated financial statements.

Recently Issued Accounting Standards

In September 2009, the FASB reached a consensus on ASU 2009-13, Revenue Recognition (Topic 605) — Multiple-Deliverable Revenue Arrangements, or ASU 2009-13, and ASU 2009-14, Software (Topic 985) — Certain Revenue Arrangements That Include Software Elements, or ASU 2009-14. ASU 2009-13 modifies the requirements that must be met for an entity to recognize revenue from the sale of a delivered item that is part of a multiple-element arrangement when other items have not yet been delivered. ASU 2009-13 eliminates the requirement that all undelivered elements must have either: (a) VSOE or (b) third-party evidence, or TPE, before an entity can recognize the portion of an overall arrangement consideration that is attributable to items that already have been delivered. In the absence of VSOE or TPE of the standalone selling price for one or more delivered or undelivered elements in a multiple-element arrangement, entities will be required to estimate the selling prices of those elements. Overall arrangement consideration will be allocated to each element (both delivered and undelivered items) based on their relative selling prices, regardless of whether those selling prices are evidenced by VSOE or TPE or are based on the entity’s estimated selling price. The residual method of allocating arrangement consideration has been eliminated. ASU 2009-14 modifies the software revenue recognition guidance to exclude from its scope tangible products that contain both software and non-software components that function together to deliver a product’s essential functionality. These new updates are effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of these ASUs will have on its consolidated financial statements.

2. Fair Value Measurements

The Company applies ASC 820 with respect to fair value measurements of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s consolidated financial statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. As defined by ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company estimates fair value utilizing market data or assumptions that market participants would use in pricing the asset or liability in a current transaction, including assumptions about risk and the risks inherent in the inputs to the valuation technique. ASC 820 prioritizes the inputs used in measuring fair value into the following hierarchy (with Level 1 as the highest priority):

Level 1		Quoted market prices in active markets for identical assets or liabilities;

Level 2		Observable inputs other than those included in Level 1 (for example, quoted prices for similar assets in active markets or quoted prices for identical assets in inactive markets); and

Level 3

Unobservable inputs reflecting management’s own assumptions about the inputs used in estimating the value of the asset.

Recurring Fair Value Measurements

The fair value hierarchy requires the use of observable market data when available. The financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels. The following tables sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at September 30, 2010 and March 31, 2010:


			Quoted Prices
			in Active		Significant
			Markets for		Other
	Balance at		Identical		Observable		Unobservable
	September 30,		Assets		Inputs		Inputs
	2010		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	106,852	$	106,852	$	—	$	—
Restricted cash		2,114		2,114		—		—


	$	108,966	$	108,966	$	—	$	—


			Quoted Prices
			in Active		Significant
			Markets for		Other
	Balance at		Identical		Observable		Unobservable
	March 31,		Assets		Inputs		Inputs
	2010		(Level 1)		(Level 2)		(Level 3)
Cash and cash equivalents	$	84,611	$	84,611	$	—	$	—
Restricted cash		2,339		2,339		—		—
Marketable securities (1)		7,158		—		—		7,158
ARS put option rights (2)		548		—		—		548


	$	94,656	$	86,950	$	—	$	7,706


(1)		Marketable securities consist of ARS.

(2)		ARS put option rights are included in other current assets.

On June 30, 2010, the earliest date allowable under the Rights Agreement, the Company exercised its ARS put option rights and put its ARS back to UBS, resulting in a net loss of $6, which is included in other income (expense) for the six months ended September 30, 2010. The ARS were sold and settled on July 1, 2010 at 100% of the $7,700 par value. The Company recorded unpaid interest of $83 from the ARS for the six months ended September 30, 2010. The Company has no outstanding ARS or ARS put option rights at September 30, 2010.

The following table presents activity in the Company’s assets measured at fair value using significant unobservable inputs (Level 3), as defined by ASC 820, as of and for the six months ended September 30, 2010:


Balance at March 31, 2010	$	7,706
Transfer in/(out) of Level 3		—
Proceeds from sale (at par)		(7,700	)
Recognized loss		(6	)


Balance at September 30, 2010	$	—

Non-Recurring Fair Value Measurements

The Company has certain assets, including inventories, tangible fixed assets, goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only when the carrying values are more than the fair values. The categorization of the framework used to price the assets is considered a Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. During the six months ended September 30, 2010, there were no adjustments to fair value of such assets.

Fair Value of Financial Instruments

The estimated fair value of financial instruments is determined using the best available market information and appropriate valuation methodologies. However, considerable judgment is necessary in interpreting market data to develop the estimates of fair value. Accordingly, the estimates presented are not necessarily indicative of the amounts that the Company could realize in a current market exchange, or the value that ultimately will be realized upon maturity or disposition. The use of different market assumptions may have a material effect on the estimated fair value amounts. The Company’s financial instruments, other than those presented in the disclosures above, include cash and cash equivalents, accounts receivables, accounts payable, and accrued liabilities. The carrying value of these assets and liabilities approximates fair value because of the short-term nature of these instruments.

3. Composition of Certain Financial Statement Captions

Accounts receivable include amounts related to maintenance and services that were billed but not yet rendered at each period end. Undelivered maintenance and services are included as a component of the deferred revenue balance.


	September 30,			March 31,
	2010			2010
Accounts receivable, excluding undelivered software, maintenance and services	$	78,632		$	72,500
Undelivered software, maintenance and implementation services billed in advance, included in deferred revenue		39,940			39,447


Accounts receivable, gross		118,572			111,947

Allowance for doubtful accounts		(6,066	)		(4,489	)


Accounts receivable, net	$	112,506		$	107,458

Inventories are summarized as follows:


	September 30,		March 31,
	2010		2010
Computer systems and components, net of reserve for obsolescence of $237	$	1,474	$	1,322
Miscellaneous parts and supplies		9		18


Inventories, net	$	1,483	$	1,340

Equipment and improvements are summarized as follows:


	September 30,			March 31,
	2010			2010
Computer and electronic test equipment	$	20,530		$	18,599
Furniture and fixtures		5,383			5,136
Leasehold improvements		2,057			1,969


		27,970			25,704
Accumulated depreciation and amortization		(19,242	)		(17,272	)


Equipment and improvements, net	$	8,728		$	8,432

Current and non-current deferred revenue are summarized as follows:


	September 30,		March 31,
	2010		2010
Maintenance	$	11,500	$	13,242
Implementation services		42,805		38,137
Annual license services		7,394		8,214
Undelivered software and other		4,038		4,516


Deferred revenue	$	65,737	$	64,109


Deferred revenue, net of current	$	797	$	474

Accrued compensation and related benefits are summarized as follows:


	September 30,		March 31,
	2010		2010
Payroll, bonus and commission	$	2,107	$	4,185
Vacation		4,881		4,766


Accrued compensation and related benefits	$	6,988	$	8,951

Other current liabilities are summarized as follows:


	September 30,		March 31,
	2010		2010
Contingent consideration related to acquisition	$	4,876	$	5,275
Users Group Meeting (UGM) deposits		2,461		8
Care services liabilities		2,113		2,336
Accrued EDI expense		2,077		2,000
Accrued royalties		897		926
Customer deposits		913		1,036
Sales tax payable		557		506
Outside commission payable		535		468
Professional services		472		391
Deferred rent		734		641
Self insurance reserve		444		516
Other accrued expenses		2,947		2,117


Other current liabilities	$	19,026	$	16,220

4. Business Combinations

On February 10, 2010, the Company acquired Opus, a provider of clinical information systems to the small hospital inpatient market, and on August 12, 2009, the Company acquired Sphere, a provider of financial information systems to the small hospital inpatient market.

The Company accounted for these acquisitions as a purchase business combination as defined in FASB ASC Topic 805, Business Combinations, or ASC 805. Under the acquisition method of accounting, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The fair value of the assets acquired and liabilities assumed represent management’s estimate of fair value. For additional disclosures regarding the Opus and Sphere acquisitions, refer to Note 5, “Business Combinations,” in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2010.

5. Goodwill

In accordance with ASC 350-20, the Company does not amortize goodwill as the goodwill has been determined to have an indefinite useful life.

Goodwill consists of the following:


	September 30,		March 31,
	2010		2010
NextGen Division
Opus Healthcare Solutions, Inc.	$	13,005	$	13,005
NextGen Inpatient Solutions, LLC		1,020		1,020
NextGen Healthcare Information Systems, Inc.		1,840		1,840

Total NextGen Division goodwill		15,865		15,865

Practice Solutions Division
Practice Management Partners, Inc.		19,485		19,485
Healthcare Strategic Initiatives		10,839		10,839

Total Practice Solutions Division goodwill		30,324		30,324


Total goodwill	$	46,189	$	46,189

6. Intangible Assets

The Company had the following intangible assets, other than capitalized software development costs, with determinable lives as of September 30, 2010:


	Customer						Software
	Relationships			Trade Name			Technology			Total
Gross carrying amount	$	10,206		$	637		$	12,119		$	22,962
Accumulated amortization		(3,069	)		(349	)		(994	)		(4,412	)


Net intangible assets	$	7,137		$	288		$	11,125		$	18,550

Activity related to the intangible assets for the six months ended September 30, 2010 is as follows:


	Customer						Software
	Relationships			Trade Name			Technology			Total
Balance as of April 1, 2010	$	7,849		$	368		$	11,928		$	20,145
Amortization (1)		(712	)		(80	)		(803	)		(1,595	)


Balance as of September 30, 2010	$	7,137		$	288		$	11,125		$	18,550


(1)		Amortization of the customer relationships and trade name intangible assets is included in operating expenses and amortization of the software technology intangible assets is included in cost of revenue for software, hardware and supplies.

The following table represents the remaining estimated amortization of intangible assets with determinable lives as of September 30, 2010:


For the year ended March 31, 2011 (remaining six months)	$	1,660
2012		3,320
2013		3,184
2014		3,055
2015 and beyond		7,331


Total	$	18,550

7. Capitalized Software Costs

The Company had the following amounts related to capitalized software development costs:


	September 30,			March 31,
	2010			2010
Gross carrying amount	$	47,135		$	41,429
Accumulated amortization		(33,336	)		(29,883	)


Net capitalized software costs	$	13,799		$	11,546

Activity related to net capitalized software costs for the six months ended September 30, 2010 is as follows:


Balance as of April 1, 2010	$	11,546
Capitalized		5,706
Amortization		(3,453	)


Balance as of September 30, 2010	$	13,799

The following table represents the remaining estimated amortization of capitalized software costs as of September 30, 2010:


For the year ended March 31, 2011 (remaining six months)	$	3,490
2012		5,554
2013		3,622
2014		1,133


Total	$	13,799

8. Share-Based Awards

Employee Stock Option Plans

In September 1998, the Company’s shareholders approved a stock option plan (the “1998 Plan”) under which 4,000,000 shares of Common Stock were reserved for the issuance of options. The 1998 Plan provides that employees, directors and consultants of the Company may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted options to purchase shares of Common Stock. The exercise price of each option granted was determined by the Board of Directors at the date of grant, and options under the 1998 Plan expire no later than ten years from the grant date. Options granted will generally become exercisable in accordance with the terms of the agreement pursuant to which they were granted. Certain option grants to directors became exercisable three months from the date of grant. Upon an acquisition of the Company by merger or asset sale, each outstanding option may be subject to accelerated vesting under certain circumstances. The 1998 Plan terminated on December 31, 2007. As of September 30, 2010, there were 281,834 outstanding options related to this Plan.

In October 2005, the Company’s shareholders approved a stock option and incentive plan (the “2005 Plan”) under which 2,400,000 shares of Common Stock were reserved for the issuance of awards, including stock options, incentive stock options and non-qualified stock options, stock appreciation rights, restricted stock, unrestricted stock, restricted stock units, performance shares, performance units (including performance options) and other share-based awards. The 2005 Plan provides that employees, directors and consultants of the Company may, at the discretion of the Board of Directors or a duly designated compensation committee, be granted awards to acquire shares of Common Stock. The exercise price of each option award shall be determined by the Board of Directors at the date of grant in accordance with the terms of the 2005 Plan, and under the 2005 Plan awards expire no later than ten years from the grant date. Options granted will generally become exercisable in accordance with the terms of the agreement pursuant to which they were granted. Upon an acquisition of the Company by merger or asset sale, each outstanding option may be subject to accelerated vesting under certain circumstances. The 2005 Plan terminates on May 25, 2015, unless terminated earlier by the Board of Directors. As of September 30, 2010, there were 502,852 outstanding options and 1,780,394 shares available for future grant related to this Plan.

Activity of all stock option plans during the six months ended September 30, 2010 is as follows:


				Weighted-		Weighted-
				Average		Average		Aggregate
				Exercise		Remaining		Intrinsic
	Number of			Price		Contractual		Value
	Shares			per Share		Life (years)		(in thousands)
Outstanding, April 1, 2010		871,963		$	43.15		4.5	$	15,945
Granted		45,000		$	56.95		7.7
Exercised		(75,548	)	$	37.34		2.6	$	2,189
Forfeited/Canceled		(56,729	)	$	56.00		6.6


Outstanding, September 30, 2010		784,686		$	43.58		4.2	$	17,836


Vested and expected to vest, September 30, 2010		768,603		$	43.42		4.1	$	17,591


Exercisable, September 30, 2010		311,122		$	33.39		2.1	$	10,243

The Company utilized the Black-Scholes valuation model for estimating the fair value of share-based compensation after the adoption of ASC 718 with the following assumptions:


	Six Months	Six Months
	Ended	Ended
	September 30,	September 30,
	2010	2009
Expected life	4.2 years	4.4 years
Expected volatility	44.3% - 44.7%	47.7% - 48.7%
Expected dividends	2.1% - 2.2%	1.9% - 2.3%
Risk-free rate	1.6% - 2.1%	2.4% - 2.5%

The weighted-average grant date fair value of stock options granted during the six months ended September 30, 2010 was $18.22 per share. The expected dividend yield is the average dividend rate during a period equal to the expected life of the option.

During the six months ended September 30, 2010 and 2009, 45,000 and 30,000 options were granted, respectively, under the 2005 Plan. The Company issues new shares to satisfy option exercises. Based on historical experience of option cancellations, the Company has estimated an annualized forfeiture rate of 2.4% for employee options and 0.0% for director options. Forfeiture rates will be adjusted over the requisite service period when actual forfeitures differ, or are expected to differ, from the estimate.

On August 3, 2010, the Board of Directors granted a total of 5,000 options under the Company’s 2005 Plan to a selected employee at an exercise price equal to the market price of the Company’s Common Stock on the date of grant ($55.24 per share). The options vest in five equal annual installments beginning August 3, 2011 and expire on August 3, 2018.

On June 4, 2010, the Board of Directors granted a total of 25,000 options under the Company’s 2005 Plan to selected employees at an exercise price equal to the market price of the Company’s Common Stock on the date of grant ($56.29 per share). The options vest in five equal annual installments beginning June 4, 2011 and expire on June 4, 2018.

On June 2, 2010, the Board of Directors granted a total of 15,000 options under the Company’s 2005 Plan to a selected employee at an exercise price equal to the market price of the Company’s Common Stock on the date of grant ($58.62 per share). The options vest in five equal annual installments beginning June 2, 2011 and expire on June 2, 2018.

Performance-Based Awards

On May 26, 2010, the Board of Directors approved its fiscal 2011 equity incentive program for certain employees to be awarded options to purchase the Company’s Common Stock. The maximum number of options available under the equity incentive program plan is 280,000, of which 115,000 are reserved for the Company’s Named Executive Officers and 165,000 for non-executive employees of the Company. Under the program, executives are eligible to receive options based on meeting certain target increases in earnings per share performance and revenue growth during fiscal year 2011. Under the program, the non-executive employees are eligible to receive options based on satisfying certain management established criteria and recommendations of senior management. The options shall be issued pursuant to one of the Company’s shareholder approved option plans, have an exercise price equal to the closing price of the Company’s shares on the date of grant, a term of eight years, and vesting in five equal annual installments commencing one year following the date of grant.

Compensation expense associated with the performance based awards under the Company’s 2011 incentive plan are initially based on the number of options expected to vest after assessing the probability that certain performance criteria will be met. Cumulative adjustments are recorded quarterly to reflect subsequent changes in the estimated outcome of performance-related conditions. The Company utilized the Black-Scholes option valuation model and recorded stock compensation expense related to the performance based awards of approximately $128 during the six months ended September 30, 2010 using the following assumptions:


		Six Months
		Ended
		September 30,
		2010
Expected life		4.2 years
Expected volatility		44.4%
Expected dividends		2.1%
Risk-free rate		1.8%

Non-vested stock option award activity, including employee stock options and performance-based awards, for the six months ended September 30, 2010, is summarized as follows:


				Weighted-
				Average
	Non-Vested			Grant-Date
	Number of			Fair Value
	Shares			per Share
Outstanding, April 1, 2010		610,836		$	15.26
Granted		45,000		$	18.22
Vested		(125,543	)	$	12.01
Forfeited/Canceled		(56,729	)	$	19.13


Outstanding, September 30, 2010		473,564		$	15.93

As of September 30, 2010, $5,822 of total unrecognized compensation costs related to stock options is expected to be recognized over a weighted-average period of 5.5 years. This amount does not include the cost of new options that may be granted in future periods or any changes in the Company’s forfeiture percentage. The total fair value of options vested during the six months ended September 30, 2010 and 2009 was $1,508 and $1,457, respectively.

Restricted Stock Units

On May 27, 2009, the Board of Directors approved its Outside Director Compensation Plan, whereby each non-employee Director is to be awarded shares of restricted stock units upon election or re-election to the Board. The restricted stock units are awarded under the 2005 Plan. Such restricted stock units vest in two equal, annual installments on the first and second anniversaries of the grant date and are nontransferable for one year following vesting. Upon each vesting of the award, one share of Common Stock shall be issued for each restricted stock unit. The weighted-average grant date fair value of $54.26 for the restricted stock units was estimated using the market price of its Common Stock on the date of grant. The fair value of these restricted stock units is amortized on a straight-line basis over the vesting period.

As of September 30, 2010, 17,146 restricted stock units were issued and approximately $220 of compensation expense was recorded under this Plan during the six months ended September 30, 2010. Restricted stock units award activity for the six months ended September 30, 2010, is summarized as follows:


				Weighted-
				Average
				Grant-Date
	Number of			Fair Value
	Shares			per Share
Outstanding, April 1, 2010		8,000		$	53.86
Granted		9,146		$	54.62
Vested		(5,698	)	$	54.43


Outstanding, September 30, 2010		11,448		$	54.18

As of September 30, 2010, $574 of total unrecognized compensation costs related to restricted stock units is expected to be recognized over a weighted-average period of 1.6 years. This amount does not include the cost of new restricted stock units that may be granted in future periods.

9. Income Taxes

The provision for income taxes for the six months ended September 30, 2010 was approximately $14,576 as compared to approximately $12,964 for the year ago period. The effective tax rates for the six months ended September 30, 2010 and 2009 were 36.4% and 36.9%, respectively. The provision for income taxes for the six months ended September 30, 2010 differs from the combined statutory rates primarily due to the impact of varying state income tax rates, tax-exempt interest income, the qualified production activities deduction and state research and development tax credits. The effective rate for the six months ended September 30, 2010 decreased from the prior year primarily due to fluctuations in the state effective tax rate and increased benefits from the qualified production activities deduction, offset by the expiration of the federal research and development tax credit statute, which occurred at the end of the fourth quarter of fiscal year 2010 and therefore was not included in the provision for the six months ended September 30, 2010.

Uncertain tax positions

As of September 30, 2010, the Company has provided a liability of $659 for unrecognized tax benefits related to various federal and state income tax matters. If recognized, $659 would impact the Company’s effective tax rate. The reserve for the six months ended September 30, 2010 increased from the year ago period by $602 due to the addition of prior year tax positions of acquired companies.

The Company’s income tax returns filed for tax years 2006 through 2008 and 2005 through 2008 are subject to examination by the federal and state taxing authorities, respectively. The Company is currently not under examination by the Internal Revenue Service or any state income tax authority. The Company does not anticipate that total unrecognized tax benefits will significantly change due to the settlement of audits or the expiration of statute of limitations within the next twelve months.

10. Earnings Per Share

Basic net income per share is based upon the weighted-average shares of Common Stock outstanding. Diluted net income per share is based on the assumption that the Company’s outstanding options are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive. Dilution is computed by applying the treasury stock method. Under this method, options are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase Common Stock at the average market price during the period. The following table reconciles the weighted-average shares outstanding for basic and diluted net income per share for the periods indicated (in thousands):


	Three Months Ended September 30,				Six Months Ended September 30,
	2010		2009		2010		2009
Net income	$	13,430	$	11,820	$	25,522	$	22,166

Basic net income per share:
Weighted-average shares outstanding — Basic		28,935		28,597		28,915		28,545


Basic net income per common share	$	0.46	$	0.41	$	0.88	$	0.78


Net income	$	13,430	$	11,820	$	25,522	$	22,166

Diluted net income per share:
Weighted-average shares outstanding — Basic		28,935		28,597		28,915		28,545
Effect of potentially dilutive securities		143		145		151		172


Weighted-average shares outstanding — Diluted		29,078		28,742		29,066		28,717


Diluted net income per common share	$	0.46	$	0.41	$	0.88	$	0.77

The computation of diluted net income per share does not include 284,000 and 268,000 options for the three and six months ended September 30, 2010, respectively, because their inclusion would have an anti-dilutive effect on net income per share.

The computation of diluted net income per share does not include 60,000 options for both the three and six months ended September 30, 2009, because their inclusion would have an anti-dilutive effect on net income per share.

11. Operating Segment Information

The Company has prepared operating segment information in accordance with ASC 280 to report components that are evaluated regularly by its chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance.

As a result of certain organizational changes during fiscal year 2010, the composition of the Company’s NextGen Division was revised to exclude the former NextGen Practice Solutions unit and the Company’s RCM entities (HSI and PMP), both of which are now administered and aggregated in the Company’s Practice Solutions Division. Following the reorganization, the Company operates three reportable operating segments (not including Corporate), comprised of the NextGen Division, the QSI Dental Division and the Practice Solutions Division.

Prior period segment results were revised to reflect this reorganization for the Company’s NextGen Division and Practice Solution Division. The results of operations related to the HSI and PMP acquisitions are included in the Practice Solutions Division. The results of operations related to the Opus and Sphere acquisitions are included in the NextGen Division.

The QSI Dental Division, co-located with the Company’s Corporate Headquarters in Irvine, California, currently focuses on developing, marketing and supporting software suites sold to dental and certain niche medical practices. In addition, the Division supports a number of medical clients that utilize the Division’s UNIX^® based medical practice management software product.

The NextGen Division, with headquarters in Horsham, Pennsylvania, and significant locations in Atlanta, Georgia and Austin, Texas, focuses principally on developing and marketing products and services for medical practices.

The three Divisions operate largely as stand-alone operations, with each Division maintaining its own distinct product lines, product platforms, development, implementation and support teams, sales staffing and branding. The three Divisions share the resources of the Company’s “corporate office” which includes a variety of accounting and other administrative functions. Additionally, there are a small but growing number of clients who are simultaneously utilizing software or services from more than one of its three Divisions.

The accounting policies of the Company’s operating segments are the same as those described in Note 1 of our Notes to Consolidated Financial Statements, “Summary of Significant Accounting Policies,” except that the disaggregated financial results of the segments reflect allocation of certain functional expense categories consistent with the basis and manner in which Company management internally disaggregates financial information for the purpose of assisting in making internal operating decisions. Certain corporate overhead costs, such as executive and accounting department personnel-related expenses, are not allocated to the individual segments by management.

Operating segment data is as follows:


	Three Months Ended September 30,						Six Months Ended September 30,
	2010			2009			2010			2009
Revenue:
QSI Dental Division	$	4,646		$	4,250		$	9,998		$	8,106
NextGen Division		64,758			56,327			130,588			108,757
Practice Solutions Division		12,053			11,121			23,798			21,473


Consolidated revenue	$	81,457		$	71,698		$	164,384		$	138,336


Operating income:
QSI Dental Division	$	967		$	901		$	2,558		$	1,565
NextGen Division		23,945			20,545			46,734			39,639
Practice Solutions Division		1,277			1,252			1,464			1,537
Unallocated corporate expense		(5,366	)		(4,085	)		(10,906	)		(7,806	)


Consolidated operating income	$	20,823		$	18,613		$	39,850		$	34,935

Management evaluates performance based on stand-alone segment operating income. Because the Company does not evaluate performance based on return on assets at the operating segment level, assets are not tracked internally by segment. Therefore, segment asset information is not presented.

All of the recorded goodwill at September 30, 2010 relates to the Company’s NextGen Division and Practice Solutions Division. As a result of the reorganization discussed above, the goodwill relating to the fiscal year 2009 acquisitions of HSI and PMP is now recorded in the Practice Solutions Division. The goodwill relating to the acquisitions of Opus and Sphere is recorded in the NextGen Division.

12. Concentration of Credit Risk

The Company had cash deposits at U.S. banks and financial institutions which exceeded federally insured limits at September 30, 2010. The Company is exposed to credit loss for amounts in excess of insured limits in the event of non-performance by the institutions; however, the Company does not anticipate non-performance by these institutions.

13. Commitments, Guarantees and Contingencies

Commitments and Guarantees

Software license agreements in both the QSI and NextGen Divisions include a performance guarantee that the Company’s software products will substantially operate as described in the applicable program documentation for a period of 365 days after delivery. To date, the Company has not incurred any significant costs associated with its performance guarantee or other related warranties and does not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties. Certain arrangements also include performance guarantees related to response time, availability for operational use, and other performance-related guarantees. Certain arrangements also include penalties in the form of maintenance credits should the performance of the software fail to meet the performance guarantees. To date, the Company has not incurred any significant costs associated with these warranties and does not expect to incur significant warranty costs in the future. Therefore, no accrual has been made for potential costs associated with these warranties.

The Company has historically offered short-term rights of return in certain sales arrangements. If the Company is able to estimate returns for these types of arrangements and all other criteria for revenue recognition have been met, revenue is recognized and these arrangements are recorded in the consolidated financial statements. If the Company is unable to estimate returns for these types of arrangements, revenue is not recognized in the consolidated financial statements until the rights of return expire, provided also, that all other criteria of revenue recognition have been met.

The Company’s standard sales agreements in the NextGen Division contain an indemnification provision pursuant to which it shall indemnify, hold harmless, and reimburse the indemnified party for losses suffered or incurred by the indemnified party in connection with any United States patent, any copyright or other intellectual property infringement claim by any third party with respect to its software. The QSI Dental Division arrangements occasionally utilize this type of language as well. As the Company has not incurred any significant costs to defend lawsuits or

settle claims related to these indemnification agreements, the Company believes that its estimated exposure on these agreements is currently minimal. Accordingly, the Company has no liabilities recorded for these indemnification obligations.

The Company has entered into marketing assistance agreements with existing users of the Company’s products which provide the opportunity for those users to earn commissions if they host specific site visits upon the Company’s request for prospective customers that directly result in a purchase of the Company’s software by the visiting prospects. Amounts earned by existing users under this program are treated as a selling expense in the period when earned.

Litigation

The Company has experienced legal claims by parties asserting that it has infringed their intellectual property rights. The Company believes that these claims are without merit and intends to defend against them vigorously; however, the Company could incur substantial costs and diversion of management resources defending any infringement claim — even if it is ultimately successful in the defense of such matter. Litigation is inherently uncertain and always difficult to predict. The Company refers you to the discussion of infringement and litigation risks in the Risk Factors section of the Company’s Annual Report on Form 10-K.

14. Subsequent Events

On October 25, 2010, the Board of Directors approved a quarterly cash dividend of $0.30 per share on the Company’s outstanding shares of Common Stock, payable to shareholders of record as of December 17, 2010 with an expected distribution date on or about January 5, 2011.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Except for the historical information contained herein, the matters discussed in this management’s discussion and analysis of financial condition and results of operations, or MD&A, including discussions of our product development plans, business strategies and market factors influencing our results, may include forward-looking statements that involve certain risks and uncertainties. Actual results may differ from those anticipated by us as a result of various factors, both foreseen and unforeseen, including, but not limited to, our ability to continue to develop new products and increase systems sales in markets characterized by rapid technological evolution, consolidation, and competition from larger, better capitalized competitors. Many other economic, competitive, governmental and technological factors could affect our ability to achieve our goals, and interested persons are urged to review any risks that may be described in “Item 1A. Risk Factors” as set forth herein and other risk factors appearing in our most recent filing on our Annual Report on Form 10-K, as supplemented by additional risk factors, if any, in our interim filings on our Quarterly Report on Form 10-Q, as well as in our other public disclosures and filings with the Securities and Exchange Commission.

This MD&A is provided as a supplement to the consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q, in order to enhance your understanding of our results of operations and financial condition and the following discussion should be read in conjunction with, and is qualified in its entirety by, the consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Historical results of operations, percentage margin fluctuations and any trends that may be inferred from the discussion below are not necessarily indicative of the operating results for any future period.

Our MD&A is organized as follows:

	•		Management Overview. This section provides a general description of our Company and operating segments, a discussion as to how we derive our revenue, background information on certain trends and developments affecting our Company, a summary of our acquisition transactions and a discussion on management’s strategy for driving revenue growth.

	•		Critical Accounting Policies and Estimates. This section discusses those accounting policies that are considered important to the evaluation and reporting of our financial condition and results of operations, and whose application requires us to exercise subjective or complex judgments in making estimates and assumptions. In addition, all of our significant accounting policies, including our critical accounting policies, are summarized in Note 1 of our Notes to Consolidated Financial Statements, “Summary of Significant Accounting Policies,” included in this Quarterly Report on Form 10-Q.

	•		Company Overview. This section provides a more detailed description of our Company, operating segments, products and services offered.

	•		Overview of Results of Operations and Results of Operations by Operating Divisions. These sections provide our analysis and outlook for the significant line items on our consolidated statements of income, as well as other information that we deem meaningful to understand our results of operations on both a consolidated basis and an operating division basis.

	•		Liquidity and Capital Resources. This section provides an analysis of our liquidity and cash flows.

	•		New Accounting Pronouncements. This section provides a summary of the most recent authoritative accounting standards and guidance that have either been recently adopted by our Company or may be adopted in the future.

Management Overview

Quality Systems, Inc., including its wholly-owned subsidiaries, is comprised of the QSI Dental Division; the NextGen Division, which consists of NextGen Healthcare Information Systems, Inc. (“NextGen”), NextGen Inpatient Solutions, LLC (“Sphere”) and Opus Healthcare Solutions, Inc. (“Opus”); and the Practice Solutions Division, which consists of Lackland Acquisition II, LLC dba Healthcare Strategic Initiatives (“HSI”) and Practice Management Partners, Inc. (“PMP”) (collectively, the “Company”, “we”, “our”, or “us”). The Company develops and markets healthcare information systems that automate certain aspects of medical and dental practices, networks of practices such as physician hospital organizations (“PHOs”) and management service organizations (“MSOs”), ambulatory care centers, community health centers, and medical and dental schools. The Company also provides revenue cycle management (“RCM”) services through the Practice Solutions Division.

The turbulence in the worldwide economy has impacted almost all industries. While healthcare is not immune to economic cycles, we believe it is more resilient than most segments of the economy. The impact of the current economic conditions on our existing and prospective clients has been mixed. We continue to see organizations that are doing fairly well operationally; however, some organizations with a large dependency on Medicaid populations are being impacted by the challenging financial condition of the many state governments in whose jurisdictions they conduct business. A positive factor for U.S. healthcare is the fact that the Obama Administration is pursuing broad healthcare reform aimed at improving issues surrounding healthcare. The American Recovery and Reinvestment Act (“ARRA”), which became law on February 17, 2009, includes more than $20 billion to help healthcare organizations modernize operations through the acquisition of health care information technology. As we closed the second quarter on September 30, 2010, the Certification Commission for Health Information Technology (CCHIT^®) announced that our EHR solution was certified as a Complete EHR and 2011/2012 compliant. This came on the heels of the Stage 1

Meaningful Use definition criteria revealed in July 2010. With the lifting of the many uncertainties, which has impacted software revenue, we believe we are well positioned to aid physicians and hospitals with their EHR decisions as they prepare to make incentive-based purchases.

On May 20, 2008, we acquired HSI, a full-service healthcare RCM company. HSI operates under the umbrella of the Company’s Practice Solutions Division. Founded in 1996, HSI provides RCM services to providers including health systems, hospitals, and physicians in private practice with an in-house team of more than 200 employees, including specialists in medical billing, coding and compliance, payor credentialing, and information technology.

On October 28, 2008, we acquired PMP, a full-service healthcare RCM company. This acquisition is also part of our growth strategy for our Practice Solutions Division. Similar to HSI, PMP operates under the umbrella of the Company’s Practice Solutions Division. Founded in 2001, PMP provides physician billing and technology management services to healthcare providers, primarily in the Mid-Atlantic region.

On August 12, 2009, we acquired Sphere, a provider of financial information systems to the small hospital inpatient market. This acquisition is also part of our strategy to expand into the small hospital market and to add new customers by taking advantage of cross selling opportunities between the ambulatory and inpatient markets.

On February 10, 2010, we acquired Opus, a provider of clinical information systems to the small hospital inpatient market. Founded in 1987 and headquartered in Austin, Texas, Opus delivers web-based clinical solutions to hospital systems and integrated health networks nationwide. This acquisition complements and will be integrated with the assets of Sphere. Both companies are established developers of software and services for the inpatient market and will operate under the Company’s NextGen Division.

Our strategy is, at present, to focus on providing software and services to medical and dental practices. The key elements of this strategy are to continue development and enhancement of select software solutions in target markets, to continue investments in our infrastructure including but not limited to product development, sales, marketing, implementation, and support, to continue efforts to make infrastructure investments within an overall context of maintaining reasonable expense discipline, to add new customers through maintaining and expanding sales, marketing and product development activities, and to expand our relationship with existing customers through delivery of add-on and complementary products and services and to continue our gold standard commitment of service in support of our customers.

Critical Accounting Policies and Estimates

The discussion and analysis of our consolidated financial statements and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate estimates, including but not limited to those related to revenue recognition, valuation of marketable securities, ARS put option rights, uncollectible accounts receivable, software development cost, intangible assets and self-insurance accruals, for reasonableness. We base our estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that may not be readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We describe our significant accounting policies in Note 2, “Summary of Significant Accounting Policies,” of our Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010. We discuss our critical accounting policies and estimates in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010. There have been no material changes in our significant accounting policies or critical accounting policies and estimates since the end of fiscal year 2010.

Company Overview

The Company is comprised of the QSI Dental Division, the NextGen Division, and the Practice Solutions Division. Operationally, HSI and PMP are considered and administered as part of the Practice Solutions Division, while Opus and Sphere operate under the NextGen Division. We primarily derive revenue by developing and marketing healthcare information systems that automate certain aspects of medical and dental practices, networks of practices such as PHOs and MSOs, ambulatory care centers, community health centers, and medical and dental schools along with comprehensive systems implementation, maintenance and support and add on complementary services such as RCM and EDI. Our systems and services provide our clients with the ability to redesign patient care and other workflow processes while improving productivity through facilitation of managed access to patient information. Utilizing our proprietary software in combination with third party hardware and software solutions, our products enable the integration of a variety of administrative and clinical information operations.

The Company, a California corporation formed in 1974, was founded with an early focus on providing information systems to dental group practices. In the mid-1980’s, we capitalized on the increasing focus on medical cost containment and further expanded our information processing systems to serve the medical market. In the mid-1990’s, we made two acquisitions that accelerated our penetration of the medical market. These two acquisitions formed the basis for the NextGen Division. Today, we serve the medical and dental markets through our NextGen Division and QSI Dental Division.

Historically, the Company has operated principally through two operating divisions: QSI Dental Division and NextGen Division. Through our acquisitions of HSI and PMP in 2008, we continued to strengthen our RCM service offerings. During fiscal year 2010, as a result of certain organizational changes, the composition of the Company’s NextGen Division was revised to exclude the former NextGen Practice Solutions unit and the Company’s RCM entities (HSI and PMP), both of which are now administered and aggregated in the Company’s Practice Solutions Division. Following the reorganization, the Company now operates three reportable operating segments (not including Corporate), comprised of the NextGen Division, the QSI Dental Division and the Practice Solutions Division. Accordingly, our results for the three and six months ended September 30, 2009 have been re-casted to reflect this change.

The following table breaks down our reported segment revenue and segment revenue growth by division for the three and six months ended September 30, 2010 and 2009:


	Segment Revenue Breakdown												Segment Revenue Growth
	Three Months Ended						Six Months Ended						Three Months Ended						Six Months Ended
	September 30,						September 30,						September 30,						September 30,
	2010			2009			2010			2009			2010			2009			2010			2009
QSI Dental Division		5.7	%		5.9	%		6.1	%		5.9	%		9.3	%		3.3	%		23.3	%		(0.9	)%
NextGen Division		79.5	%		78.6	%		79.4	%		78.6	%		15.0	%		2.7	%		20.1	%		2.6	%
Practice Solutions Division		14.8	%		15.5	%		14.5	%		15.5	%		8.4	%		N/A			10.8	%		N/A


Consolidated		100.0	%		100.0	%		100.0	%		100.0	%		13.6	%		21.6	%		18.8	%		21.1	%

The QSI Dental Division, co-located with our Corporate Headquarters in Irvine, California, currently focuses on developing, marketing and supporting software suites sold to dental and certain niche medical practices. In addition, the Division supports a number of medical clients that utilize its UNIX^® based medical practice management software product and its Software as a Service, or SaaS model, based NextDDS financial and clinical software.

The QSI Dental Division’s practice management software suite utilizes a UNIX^® operating system. Its Clinical Product Suite (“CPS”) utilizes a Windows NT^® operating system and can be fully integrated with the practice management software from each Division. CPS incorporates a wide range of clinical tools including, but not limited to, periodontal charting and digital imaging of X-ray and inter-oral camera images as part of the electronic patient record. The Division develops, markets, and manages our EDI/connectivity applications. Our QSInet Application Service Provider (“ASP/Internet”) offering is also developed and marketed by the Division.

In July 2009, we licensed source code from PlanetDDS, Inc. that allows us to deliver hosted, web-based SaaS model practice management and clinical software solutions to the dental industry. This new software solution (NextDDS) is being marketed primarily to the multi-location dental group practice market in which the Division has historically been a dominant player. NextDDS brings the QSI Dental Division to the forefront of the emergence of internet based applications and cloud computing and represents a significant growth opportunity for the Division to sell both to its existing customer base as well as new customers.

The NextGen Division, with headquarters in Horsham, Pennsylvania, and significant locations in Atlanta, Georgia and Austin, Texas, provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations.

The NextGen Division develops and sells proprietary electronic medical records software and practice management systems under the NextGen product name. Major product categories of the NextGen suite include Electronic Health Records (“NextGen^ehr”), Enterprise Practice Management (“NextGen^epm”), Enterprise Appointment Scheduling (“NextGen^eas”), Enterprise Master Patient Index (“NextGen^epi”), NextGen Image Control System (“NextGen^ics”), Managed Care Server (“NextGen^mcs”), Electronic Data Interchange, System Interfaces, Internet Operability (“NextGen^web”), a Patient-centric and Provider-centric Web Portal solution (“NextMD.com”), NextGen Express, a scaled-down version of NextGen^ehr designed for small practices and NextGen Community Health Solution (“NextGen^chs”). The NextGen Division also offers optional NextGen Hosting Solutions to new and existing customers. NextGen products utilize Microsoft Windows technology and can operate in a client-server environment as well as via private intranet, the Internet, or in an ASP environment.

The Practice Solutions Division, with locations in St. Louis, Missouri and Hunt Valley, Maryland, focuses primarily on providing physician practices with RCM services, primarily billing and collection services for medical practices. This Division combines a web-delivered SaaS model and the NextGen^epm software platform to execute its service offerings. We intend to transition our customer base onto the NextGen platform. The Practice Solutions Division provides technology solutions and consulting services to cover the full spectrum of providers’ revenue cycle needs from patient access to claims denials.

The Divisions operate largely as stand-alone operations, with each Division maintaining its own distinct product lines, product platforms, development, implementation and support teams, sales staffing and branding. The three Divisions share the resources of our “corporate office,” which includes a variety of accounting and other administrative functions. Additionally, there are a small but growing number of clients who are simultaneously utilizing software or services from more than one of our three Divisions.

The QSI Dental and NextGen Divisions develop and market practice management software that is designed to automate and streamline a number of the administrative functions required for operating a medical or dental practice. Examples of practice management software functions include scheduling and billing capabilities. It is important to note that in both the medical and dental environments, practice management software systems have already been implemented by the vast majority of practices. Therefore, we actively compete for the replacement market.

In addition, the QSI Dental and NextGen Divisions develop and market software that automates the patient record. Therefore, we are typically competing to replace paper-based patient record alternatives as opposed to replacing previously purchased systems.

We make available EDI capabilities and connectivity services to our customers. The EDI/connectivity capabilities encompass direct interfaces between our products and external third party systems, as well as transaction-based services. EDI products are intended to automate a number of manual, often paper-based or telephony intensive communications between patients and/or providers and/or payors. Two of the more common EDI services are forwarding insurance claims electronically from providers to payors and assisting practices with issuing statements to patients. Most client practices utilize at least some of these services from us or one of our competitors. Other EDI/connectivity services are used more sporadically by client practices. We typically compete to displace incumbent vendors for claims and statements accounts and attempt to increase usage of other elements in our EDI/connectivity product line. In general, EDI services are only sold to those accounts utilizing software from either the QSI Dental or NextGen Divisions.

We continue to pursue product and service enhancement initiatives within each Division. The majority of such expenditures are currently targeted to the NextGen Division product line and client base.

Overview of Our Results

Consolidated revenue increased 18.8% and income from operations grew by 14.4% in the six months ended September 30, 2010 versus the same period in 2009. For the six months ended September 30, 2010, revenue was positively impacted by growth in recurring revenue, including maintenance, EDI and RCM revenue, which grew 23.1%, 17.4% and 22.7%, respectively.

Income from operations was negatively impacted by amortization of the software technology intangible asset related to the Opus acquisition that is included in cost of sales, higher selling, general and administrative expenses, which was primarily a result of increased headcount expenses and selling related expenses at the NextGen Division, business integration expenses at the Practice Solution Division as well as higher corporate related expenses and increased research and development costs.

We do not believe the revenue mix changes noted above represent a change in the overall purchasing environment. On top of the potential benefits from the ARRA, we have benefited and hope to continue to benefit from the increased demands on healthcare providers for greater efficiency and lower costs, as well as increased adoption rates for electronic health records and other technology in the healthcare arena.

While we expect to benefit from the increasing demands for greater efficiency as well as government support for increased adoption of electronic health records, the current economic environment, combined with unpredictability of the federal government’s plans to promote increased adoption of electronic medical records, makes the near term achievement of such benefits and, ultimately, their impact on system sales, uncertain.

NextGen Division

NextGen Division revenue increased 20.1% in the six months ended September 30, 2010 and divisional operating income (excluding unallocated corporate expenses) increased 17.9% as compared to the prior year period. Organic revenue growth in the NextGen Division was 13.4% for the six months ended September 30, 2010.

The acquisitions of Opus and Sphere in fiscal year 2010 added approximately $7.0 million in revenue for the six months ended September 30, 2010 as compared to the same period a year ago.

Recurring revenue, consisting of maintenance and EDI revenue, increased 23.5% to $66.7 million from $54.0 million in the same period a year ago and accounted for 51.1% of total NextGen Division revenue during the six months ended September 30, 2010. In the same period a year ago, recurring revenue represented 49.7% of total divisional revenue.

During the six months ended September 30, 2010, we added staffing resources and increased our investment in research and development in anticipation of future growth from the ARRA. Our goals include taking maximum advantage of future benefits related to the ARRA and continuing to further enhance our existing products, including continued efforts to maintain our status as a qualified vendor under the ARRA, integrating our inpatient and ambulatory software products, developing new products for targeted markets, continuing to add new customers, selling additional software and services to existing customers, expanding penetration of connectivity and other services to new and existing customers, and capitalizing on growth and cross selling opportunities within the Practice Solutions Division and the recently acquired acute care software product lines.

The NextGen Division’s growth has come in part from investments in sales and marketing activities including a revamped NextGen.com Web site, new NextGen logo, new marketing campaigns, trade show attendance, and other expanded advertising and marketing expenditures. We have also benefited from winning numerous industry awards for the NextGen Division’s flagship NextGen^ehr and NextGen^epm software products and more recently in 2010 for its NextGen HIE product. Further, the increasing acceptance of electronic records technology in the healthcare industry continues to provide growth opportunities.

QSI Dental Division

QSI Dental Division revenue increased 23.3% in the six months ended September 30, 2010 and divisional operating income (excluding unallocated corporate expenses) increased 63.5% as compared to the prior year period.

An increase in system sales revenue was the chief contributor to the operating income results in the six months ended September 30, 2010.

In July 2009, we licensed source code from PlanetDDS, Inc. that allows us to deliver hosted, web-based SaaS practice management and clinical software solutions to the dental industry. This new software solution (NextDDS) is being be marketed primarily to the multi-location dental group practice market in which the QSI Dental Division has historically been a dominant player. NextDDS brings the QSI Dental Division to the forefront of the emergence of internet based applications and cloud computing and represents a significant growth opportunity for us to sell both to our existing customer base as well as new customers.

Our goal for the QSI Dental Division is to maximize profit performance given the constraints represented by a relatively weak purchasing environment in the dental group practice market while taking advantage of opportunities with the new NextDDS product. The QSI Dental Division also intends to leverage the NextGen Division’s sales force to sell its dental electronic medical records software to practices that provide both medical and dental services such as Federal Qualified Health Centers, which are receiving grants as part of the ARRA.

Practice Solutions Division

Practice Solutions Division revenue increased 10.8% in the six months ended September 30, 2010 and divisional operating income (excluding unallocated corporate expenses) decreased 4.7% as compared to the prior year period. The Practice Solutions Division benefited from organic growth achieved through cross selling RCM services to existing NextGen Division customers.

Operating income as a percentage of revenue declined to approximately 6.2% of revenue in the six months ended September 30, 2010 versus 7.2% of revenue in the prior year period primarily as a result of a smaller amount of software sales to RCM customers compared to the prior year period as well as costs related to transitioning to the NextGen platform including training of staff and initial set up and other costs related to achieving higher production volumes as well as integration expenses related to consolidating the operations of the two entities that make up the Practice Solutions Division.

The following table sets forth for the periods indicated the percentage of net revenue represented by each item in our consolidated statements of income (certain percentages below may not sum due to rounding):


	Three Months Ended September 30,						Six Months Ended September 30,
(Unaudited)	2010			2009			2010			2009
Revenues:
Software, hardware and supplies		25.0	%		31.9	%		27.5	%		29.4	%
Implementation and training services		5.5			4.7			5.4			4.9


System sales		30.5			36.6			32.8			34.3

Maintenance		33.8			30.0			32.3			31.2
Electronic data interchange services		12.5			12.3			12.1			12.3
Revenue cycle management and related services		13.7			12.4			13.4			12.9
Other services		9.5			8.8			9.4			9.3


Maintenance, EDI, RCM and other services		69.5			63.4			67.2			65.7


Total revenues		100.0			100.0			100.0			100.0


Cost of revenue:
Software, hardware and supplies		5.8			5.2			6.6			4.7
Implementation and training services		4.3			4.6			3.9			4.5


Total cost of system sales		10.0			9.8			10.6			9.1

Maintenance		4.0			4.5			4.1			4.5
Electronic data interchange services		8.3			8.6			8.2			8.7
Revenue cycle management and related services		10.1			9.6			10.0			9.7
Other services		4.6			7.0			4.9			7.1


Total cost of maintenance, EDI, RCM and other services		27.0			29.7			27.1			30.1

Total cost of revenue		37.0			39.5			37.7			39.2


Gross profit		63.0			60.5			62.3			60.8

Operating expenses:
Selling, general and administrative		30.5			28.0			31.1			29.0
Research and development costs		6.4			6.1			6.5			6.0
Amortization of acquired intangible assets		0.5			0.5			0.5			0.5


Total operating expenses		37.5			34.6			38.0			35.6

Income from operations		25.6			26.0			24.2			25.3

Interest income		0.2			0.1			0.1			0.1
Other income, net		0.1			0.0			0.0			0.0


Income before provision for income taxes		25.8			26.0			24.4			25.4
Provision for income taxes		9.3			9.6			8.9			9.4


Net income		16.5	%		16.5	%		15.5	%		16.0	%

Comparison of the Three Months Ended September 30, 2010 and September 30, 2009

Net Income. The Company’s net income for the three months ended September 30, 2010 was $13.4 million or $0.46 per share on a basic and fully diluted basis. In comparison, we earned $11.8 million or $0.41 per share on a basic and fully diluted basis for the three months ended September 30, 2009. The increase in net income for the three months ended September 30, 2010 was achieved primarily through the following:

•

a 13.6% increase in consolidated revenue, including an increase of $8.4 million in revenue from our NextGen Division, an increase of $0.4 million from our QSI Dental Division, and an increase of $0.9 million in revenue from our Practice Solutions Division;

•

a 15.0% increase in NextGen Division revenue, which accounted for 79.5% of consolidated revenue; and

•

an increase of recurring revenue, including RCM, maintenance, and EDI revenue, offset by an increase in selling, general and administrative expenses as a percentage of revenue related to higher selling, general and corporate expenses.

Revenue. Revenue for the three months ended September 30, 2010 increased 13.6% to $81.5 million from $71.7 million for the three months ended September 30, 2009. NextGen Division revenue increased 15.0% to $64.8 million from $56.3 million in the three months ended September 30, 2009, while QSI Dental Division revenue increased 9.3% during that same period to $4.6 million from $4.3 million and Practice Solutions Division revenue increased 8.4% during that same period to $12.1 million from $11.1 million.

System Sales. Revenue earned from Company-wide sales of systems for the three months ended September 30, 2010 decreased 5.2% to $24.9 million from $26.2 million in the prior year period.

Our decrease in revenue from sales of systems was principally the result of a decrease in software revenue. Software revenue has been negatively impacted by uncertainty over the final rules surrounding incentives provided under the ARRA.

The following table breaks down our reported system sales into software, hardware, third party software, supplies, and implementation and training services components by division (in thousands):


			Hardware, Third		Implementation
			Party Software		and Training		Total System
	Software		and Supplies		Services		Sales
Three months ended September 30, 2010
QSI Dental Division	$	565	$	388	$	271	$	1,224
NextGen Division		17,571		1,799		4,139		23,509
Practice Solutions Division		45		7		89		141


Consolidated	$	18,181	$	2,194	$	4,499	$	24,874


Three months ended September 30, 2009
QSI Dental Division	$	557	$	204	$	145	$	906
NextGen Division		18,744		2,278		3,110		24,132
Practice Solutions Division		1,073		—		125		1,198


Consolidated	$	20,374	$	2,482	$	3,380	$	26,236

NextGen Division software license revenue decreased 6.3% in the three months ended September 30, 2010 versus the same period last year. The Division’s software revenue accounted for 74.7% of divisional system sales revenue during the three months ended September 30, 2010, compared to 77.7% during the same period a year ago. Software license revenue continues to be an area of primary emphasis for the NextGen Division. The Opus acquisition, which closed in February 2010, contributed approximately $0.9 million to the NextGen Division’s software license revenue during the three months ended September 30, 2010.

During the three months ended September 30, 2010, 7.7% of the NextGen Division’s system sales revenue was represented by hardware and third party software compared to 9.4% during same period a year ago. The number of customers who purchase hardware and third party software and the dollar amount of hardware and third party software revenue fluctuates each quarter depending on the needs of customers. The inclusion of hardware and third party software in the Division’s sales arrangements is typically at the request of our customers.

Implementation and training revenue related to system sales at the NextGen Division increased 33.1% in the three months ended September 30, 2010 compared the prior year period. The amount of implementation and training services revenue is dependent on several factors, including timing of customer implementations, the availability of qualified staff, and the mix of services being rendered. The number of implementation and training staff increased during the three months ended September 30, 2010 versus the same period in 2009 in order to accommodate the increased amount of implementation services sold in conjunction with increased software sales. In order to achieve growth in this area, additional staffing increases and additional training facilities are anticipated, though actual future increases in revenue and staff will depend upon the availability of qualified staff, business mix and conditions, and our ability to retain current staff members.

For the QSI Dental Division, total system sales increased $0.3 million, or 35.1%, to $1.2 million in the three months ended September 30, 2010 as compared to $0.9 million the prior year period. Systems sales in the QSI Dental Division were positively impacted by greater joint sales of dental and medical software to Federally Qualified Health Centers. In addition, the Division began selling the SaaS based NextDDS product during fiscal year 2010.

For the Practice Solutions Division, total system sales decreased by 88.2% in the three months ended September 30, 2010 as compared to the prior year period. Systems sales revenue within the Practice Solutions Division is composed of sales to existing RCM customers only and can fluctuate given the size of the current customer base of the Practice Solutions Division.

Maintenance, EDI, RCM and Other Services. For the three months ended September 30, 2010, Company-wide revenue from maintenance, EDI, RCM and other services grew 24.5% to $56.6 million from $45.5 million in the prior year period. The increase in this category resulted primarily from an increase in maintenance, EDI and other services revenue from the NextGen Division and RCM revenue from the Practice Solutions Division. Total NextGen Division maintenance revenue for the three months ended September 30, 2010 grew 30.4% to $25.7 million from $19.7 million in the same prior year period while EDI revenue grew 17.9% to $8.9 million compared to $7.5 million during the same prior year period. Other services revenue for the NextGen Division for the three months ended September 30, 2010, which consists primarily of third party annual software license renewals, follow-on training hours, consulting services and hosting services, increased 34.6% to $6.7 million from $5.0 million in the same prior year period, primarily due to increases in third party annual software licenses, consulting services and hosting services revenue. QSI Dental Division maintenance, EDI and other revenue remained consistent at $3.4 million in the three months ended September 30, 2010 as compared to $3.3 million in the three months ended September 30, 2009. For the three months ended September 30, 2010, RCM revenue grew $2.3 million to $11.2 million compared to $8.9 million in the prior year period.

The following table details maintenance, EDI, RCM, and other services revenue by category for the three months ended September 30, 2010 and 2009 (in thousands):


	Maintenance		EDI		RCM		Other		Total
Three months ended September 30, 2010
QSI Dental Division	$	1,821	$	1,291	$	—	$	310	$	3,422
NextGen Division		25,668		8,851		—		6,730		41,249
Practice Solutions Division		40		—		11,175		697		11,912


Consolidated	$	27,529	$	10,142	$	11,175	$	7,737	$	56,583


Three months ended September 30, 2009
QSI Dental Division	$	1,786	$	1,288	$	—	$	271	$	3,345
NextGen Division		19,687		7,508		—		4,999		32,194
Practice Solutions Division		2		—		8,888		1,033		9,923


Consolidated	$	21,475	$	8,796	$	8,888	$	6,303	$	45,462

The growth in maintenance revenue for the NextGen Division has come from new customers that have been added each quarter, existing customers who have purchased additional licenses, and our relative success in retaining existing maintenance customers as well as a recent price increase during the quarter ended September 30, 2010. NextGen’s EDI revenue growth has come from new customers and from further penetration of the Division’s existing customer base. The growth in RCM revenue has come from new customers that have been acquired from cross selling opportunities with the NextGen customer base. We intend to continue to promote maintenance, EDI and RCM services to both new and existing customers.

Cost of Revenue. Cost of revenue for the three months ended September 30, 2010 increased 6.4% to $30.1 million from $28.3 million in the three months ended September 30, 2009 and the cost of revenue as a percentage of revenue decreased to 37.0% from 39.5% due to the fact that the rate of growth in cost of revenue grew slower than the aggregate revenue growth rate for the Company.

The following table details revenue and cost of revenue on a consolidated and divisional basis for the three months ended September 30, 2010 and 2009 (in thousands):


	Three Months Ended September 30,
	2010		%			2009		%
QSI Dental Division
Revenue	$	4,646		100.0	%	$	4,250		100.0	%
Cost of revenue		2,255		48.5	%		1,818		42.8	%


Gross profit	$	2,391		51.5	%	$	2,432		57.2	%


NextGen Division
Revenue	$	64,758		100.0	%	$	56,327		100.0	%
Cost of revenue		19,403		30.0	%		19,273		34.2	%


Gross profit	$	45,355		70.0	%	$	37,054		65.8	%


Practice Solutions Division
Revenue	$	12,053		100.0	%	$	11,121		100.0	%
Cost of revenue		8,470		70.3	%		7,220		64.9	%


Gross profit	$	3,583		29.7	%	$	3,901		35.1	%


Consolidated
Revenue	$	81,457		100.0	%	$	71,698		100.0	%
Cost of revenue		30,128		37.0	%		28,311		39.5	%


Gross profit	$	51,329		63.0	%	$	43,387		60.5	%

Gross profit margins at the NextGen Division for the three months ended September 30, 2010 increased to 70.0% compared to 65.8% for the three months ended September 30, 2009 because approximately $1.1 million of hardware and third party software revenue was on backorder and not recognized. Gross profit margins at the QSI Dental Division for the three months ended September 30, 2010 decreased to 51.5% from 57.2% for the three months ended September 30, 2009 primarily as a result of a higher percentage of payroll and related benefits in the three months ended September 30, 2010 as compared to the same period a year ago. Gross margin in the Practice Solutions Division decreased to 29.7% for the three months ended September 30, 2010 as compared to 35.1% in the prior year period because the prior year period gross margin was positively impacted by $1.2 million of software license sales as compared to $0.1 million of software sales recorded in the three months ended September 30, 2010.

The following table details the individual components of cost of revenue and gross profit as a percentage of total revenue on a consolidated and divisional basis for the three months ended September 30, 2010 and 2009:


	Hardware,			Payroll and
	Third Party			Related									Total Cost
	Software			Benefits			EDI			Other			of Revenue			Gross Profit
Three months ended September 30, 2010
QSI Dental Division		7.5	%		19.1	%		13.2	%		8.7	%		48.5	%		51.5	%
NextGen Division		2.5	%		11.5	%		8.2	%		7.8	%		30.0	%		70.0	%
Practice Solutions Division		0.1	%		43.2	%		0.0	%		27.0	%		70.3	%		29.7	%


Consolidated		2.5	%		16.6	%		7.3	%		10.6	%		37.0	%		63.0	%


Three months ended September 30, 2009
QSI Dental Division		7.6	%		13.6	%		16.9	%		4.7	%		42.8	%		57.2	%
NextGen Division		4.4	%		12.6	%		10.5	%		6.7	%		34.2	%		65.8	%
Practice Solutions Division		0.0	%		41.9	%		0.0	%		23.0	%		64.9	%		35.1	%


Consolidated		3.9	%		18.4	%		8.6	%		8.6	%		39.5	%		60.5	%

The decrease in our consolidated cost of revenue as a percentage of revenue between the three months ended September 30, 2010 and 2009 is primarily attributable to lower consolidated hardware and third party software expense, payroll and related benefits expense, and lower EDI costs as a percentage of revenue. Other expense, which primarily consists of third party annual license and hosting costs, increased to 10.6% of total revenue during the three months ended September 30, 2010 as compared to 8.6% for the same period a year ago.

During the three months ended September 30, 2010, hardware and third party software constituted a lower portion of cost of revenue compared to the prior year period in the NextGen Division. The number of customers who purchase hardware and third party software and the dollar amount of hardware and third party software purchased fluctuates each quarter depending on the needs of our customers.

Our payroll and benefits expense associated with delivering our products and services decreased to 16.6% of consolidated revenue in the three months ended September 30, 2010 compared to 18.4% during the same period last year. The absolute level of consolidated payroll and benefit expenses grew from $12.3 million in the three months ended September 30, 2009 to $13.5 million in the three months ended September 30, 2010, an increase of 9.6%, or approximately $1.2 million. Of the $1.2 million increase, approximately $0.5 million of the increase is related to the Practice Solutions Division. RCM is a service business, which inherently has higher percentage of payroll costs as a percentage of revenue. For the NextGen Division, an increase of approximately $0.4 million was related to increased headcount and payroll and benefits expense associated with delivering products and services. Payroll and benefits expense associated with delivering products and services in the QSI Dental Division increased $0.3 million from $0.6 million in the three months ended September 30, 2009 to $0.9 million in the three months ended September 30, 2010.

As a result of the foregoing events and activities, the gross profit percentage for the Company increased for the three months ended September 30, 2010 versus the prior year period.

We anticipate continued additions to headcount in all three Divisions in areas related to delivering products and services in future periods, but due to the uncertainties in the timing of our sales arrangements, our sales mix, the acquisition and training of qualified personnel, and other issues, we cannot accurately predict if related headcount expense as a percentage of revenue will increase or decrease in the future.

Selling, General and Administrative Expenses. Selling, general and administrative expenses for the three months ended September 30, 2010 increased 23.8% to $24.8 million as compared to $20.1 million for the prior year period. The increase in these expenses resulted primarily from:

	•		$3.6 million increase in salaries and related benefit expenses primarily as a result of headcount additions;

	•		$0.9 million increase due to a full quarter of selling and administrative expenses from Opus, which was acquired on February 10, 2010; and

	•		$0.3 million net increase in other selling and administrative expenses.

Share-based compensation expense was approximately $0.7 million and $0.8 million for the three months ended September 30, 2010 and 2009, respectively, and is included in the aforementioned amounts. Selling, general and administrative expenses as a percentage of revenue increased from 28.0% in the three months ended September 30, 2009 to 30.5% in the three months ended September 30, 2010.

We do not anticipate significant increases in expenditures for trade shows, advertising and the employment of additional sales and administrative staff at the NextGen Division until additional revenue growth is achieved. We anticipate future increases in corporate expenditures being made in a wide range of areas including professional services and investments in system applications across the Company. While we expect selling, general and administrative expenses to increase on an absolute basis, we cannot accurately predict the impact these additional expenditures will have on selling, general and administrative expenses as a percentage of revenue.

Research and Development Costs. Research and development costs for the three months ended September 30, 2010 and 2009 were $5.2 million and $4.3 million, respectively. The increases in research and development expenses were due in part to increased investment in the NextGen Division product line. The Opus and Sphere acquisitions added $0.5 million in research and development expenses during the period ended September 30, 2010. Additions to capitalized software costs offset increases in research and development costs. For the three months ended September 30, 2010, $3.2 million was added to capitalized software costs while $1.5 million was capitalized during the three months ended September 30, 2009 as we continue to enhance our software to meet the Meaningful Use definitions under the ARRA. Research and development costs as a percentage of revenue increased to 6.4% in the three months ended September 30, 2010 from 6.1% for the same period in 2009. Research and development expenses are expected to continue at or above current dollar levels. The application of ASC 718 did not have a significant effect to research and development costs in the three months ended September 30, 2010 and 2009.

Interest and Other Income. Interest and other income for the three months ended September 30, 2010 and 2009 were $0.2 million and $0.1 million, respectively. Interest and other income consist primarily of dividends and interest earned on our investments.

Our investment policy is determined by our Board of Directors. We currently maintain our cash in very liquid short term assets including tax exempt and taxable money market funds and short-term U.S. Treasury securities with original maturities of less than 90 days. Our Board of Directors continues to review alternate uses for our cash including, but not limited to, payment of a special dividend, initiation of a stock buyback program, an expansion of our investment policy to include investments with longer maturities of greater than 90 days, or other items. Additionally, it is possible that we will utilize some or all of our cash to fund acquisitions or other similar business activities. Any or all of these programs could significantly impact our investment income in future periods.

Provision for Income Taxes. The provision for income taxes for the three months ended September 30, 2010 was approximately $7.6 million as compared to approximately $6.9 million for the corresponding period a year ago. The effective tax rates were 36.1% and 36.7% for the three months ended September 30, 2010 and 2009, respectively. The effective rate for the three months ended September 30, 2010 decreased from the prior year primarily due to fluctuations in the state effective tax rate and increased benefits from the qualified production activities deduction, offset by the expiration of the federal research and development tax credit statute, which occurred at the end of the fourth quarter of fiscal year 2010 and therefore was not included in the provision for the three months ended September 30, 2010.

Comparison of the Six Months Ended September 30, 2010 and September 30, 2009

Net Income. The Company’s net income for the six months ended September 30, 2010 was $25.5 million or $0.88 per share on a basic and fully diluted basis. In comparison, we earned $22.2 million or $0.78 per share on a basic and $0.77 per share on a fully diluted basis for the six months ended September 30, 2009. The increase in net income for the six months ended September 30, 2010 was achieved primarily through the following:

•

a 18.8% increase in consolidated revenue, including an increase of $21.8 million in revenue from our NextGen Division, an increase of $1.9 million from our QSI Dental Division, and an increase of $2.3 million in revenue from our Practice Solutions Division;

•

a 20.1% increase in NextGen Division revenue, which accounted for 79.4% of consolidated revenue; and

•

an increase of recurring revenue, including RCM, maintenance, and EDI revenue, offset by an increase in selling, general and administrative expenses and research and development costs.

Revenue. Revenue for the six months ended September 30, 2010 increased 18.8% to $164.4 million from $138.3 million for the six months ended September 30, 2009. NextGen Division revenue increased 20.1% to $130.6 million from $108.8 million in the six months ended September 30, 2009, while QSI Dental Division revenue increased 23.3% during that same period to $10.0 million from $8.1 million and Practice Solutions Division revenue increased 10.8% during that same period to $23.8 million from $21.5 million.

System Sales. Revenue earned from Company-wide sales of systems for the six months ended September 30, 2010 increased 13.6% to $53.9 million from $47.5 million in the prior year period.

Our increase in revenue from sales of systems was principally the result of a 13.4% increase in category revenue at our NextGen Division, whose sales in this category increased from $44.4 million during the six months ended September 30, 2009 to $50.4 million during the six months ended September 30, 2010. This increase was driven by higher sales of software to both new and existing clients, as well as increases in hardware and third party software and implementation and training services revenue.

The following table breaks down our reported system sales into software, hardware, third party software, supplies, and implementation and training services components by division (in thousands):


			Hardware, Third		Implementation
			Party Software		and Training		Total System
	Software		and Supplies		Services		Sales
Six months ended September 30, 2010
QSI Dental Division	$	1,439	$	1,271	$	507	$	3,217
NextGen Division		37,181		5,035		8,159		50,375
Practice Solutions Division		198		7		141		346


Consolidated	$	38,818	$	6,313	$	8,807	$	53,938


Six months ended September 30, 2009
QSI Dental Division	$	739	$	457	$	354	$	1,550
NextGen Division		34,731		3,374		6,303		44,408
Practice Solutions Division		1,331		—		180		1,511


Consolidated	$	36,801	$	3,831	$	6,837	$	47,469

NextGen Division software license revenue increased 7.1% in the six months ended September 30, 2010 versus the same period last year. The Division’s software revenue accounted for 73.8% of divisional system sales revenue during the six months ended September 30, 2010, compared to 78.2% during the same period a year ago. Software license revenue growth continues to be an area of primary emphasis for the NextGen Division. The Opus acquisition, which closed in February 2010, contributed approximately $1.7 million to the NextGen Division’s software license revenue during the six months ended September 30, 2010.

During the six months ended September 30, 2010, 10.0% of the NextGen Division’s system sales revenue was represented by hardware and third party software compared to 7.6% during same period a year ago. The number of customers who purchase hardware and third party software and the dollar amount of hardware and third party software revenue fluctuates each quarter depending on the needs of customers. The inclusion of hardware and third party software in the Division’s sales arrangements is typically at the request of our customers.

Implementation and training revenue related to system sales at the NextGen Division increased 29.4% in the six months ended September 30, 2010 compared the prior year period. The amount of implementation and training services revenue is dependent on several factors, including timing of customer implementations, the availability of qualified staff, and the mix of services being rendered. The number of implementation and training staff increased during the six months ended September 30, 2010 versus the same period in 2009 in order to accommodate the increased amount of implementation services sold in conjunction with increased software sales.

For the QSI Dental Division, total system sales increased $1.6 million, or 107.5%, to $3.2 million in the six months ended September 30, 2010 as compared to $1.6 million the prior year period. Systems sales in the QSI Dental Division were positively impacted by greater joint sales of dental and medical software to Federally Qualified Health Centers. In addition, the Division began selling the SaaS based NextDDS product during fiscal year 2010.

For the Practice Solutions Division, total system sales decreased by 77.1% in the six months ended September 30, 2010 as compared to the prior year period. Systems sales revenue within the Practice Solutions Division is composed of sales to existing RCM customers only.

Maintenance, EDI, RCM and Other Services. For the six months ended September 30, 2010, Company-wide revenue from maintenance, EDI, RCM and other services grew 21.5% to $110.4 million from $90.9 million in the prior year period. The increase in this category resulted primarily from an increase in maintenance, EDI and other services revenue from the NextGen Division and RCM revenue from the Practice Solutions Division. Total NextGen Division maintenance revenue for the six months ended September 30, 2010 grew 24.7% to $49.3 million from $39.5 million in the same prior year period while EDI revenue grew 20.2% to $17.4 million compared to $14.5 million during the same prior year period. Other services revenue for the NextGen Division for the six months ended September 30, 2010, which consists primarily of third party annual software license renewals, follow-on training hours, consulting services and hosting services, increased 30.5% to $13.5 million from $10.3 million in the same prior year period, primarily due to increases in third party annual software licenses and hosting services revenue. QSI Dental Division maintenance, EDI and other revenue increased 3.4% to $6.8 million in the six months ended September 30, 2010 as compared to $6.6 million in the six months ended September 30, 2009. For the six months ended September 30, 2010, RCM revenue grew $4.0 million to $21.9 million compared to $17.9 million in the prior year period.

The following table details maintenance, EDI, RCM, and other services revenue by category for the six months ended September 30, 2010 and 2009 (in thousands):


	Maintenance		EDI		RCM		Other		Total
Six months ended September 30, 2010
QSI Dental Division	$	3,658	$	2,515	$	—	$	608	$	6,781
NextGen Division		49,329		17,391		—		13,493		80,213
Practice Solutions Division		78		—		21,947		1,427		23,452


Consolidated	$	53,065	$	19,906	$	21,947	$	15,528	$	110,446


Six months ended September 30, 2009
QSI Dental Division	$	3,567	$	2,491	$	—	$	499	$	6,557
NextGen Division		39,543		14,467		—		10,338		64,348
Practice Solutions Division		5		—		17,880		2,077		19,962


Consolidated	$	43,115	$	16,958	$	17,880	$	12,914	$	90,867

Cost of Revenue. Cost of revenue for the six months ended September 30, 2010 increased 14.4% to $62.0 million from $54.2 million in the six months ended September 30, 2009 and the cost of revenue as a percentage of revenue decreased to 37.7% from 39.2% due to the fact that the rate of growth in cost of revenue grew slower than the aggregate revenue growth rate for the Company.

The following table details revenue and cost of revenue on a consolidated and divisional basis for the six months ended September 30, 2010 and 2009 (in thousands):


	Six Months Ended September 30,
	2010		%			2009		%
QSI Dental Division
Revenue	$	9,998		100.0	%	$	8,106		100.0	%
Cost of revenue		4,647		46.5	%		3,609		44.5	%


Gross profit	$	5,351		53.5	%	$	4,497		55.5	%


NextGen Division
Revenue	$	130,588		100.0	%	$	108,757		100.0	%
Cost of revenue		40,467		31.0	%		35,877		33.0	%


Gross profit	$	90,121		69.0	%	$	72,880		67.0	%


Practice Solutions Division
Revenue	$	23,798		100.0	%	$	21,473		100.0	%
Cost of revenue		16,873		70.9	%		14,714		68.5	%


Gross profit	$	6,925		29.1	%	$	6,759		31.5	%


Consolidated
Revenue	$	164,384		100.0	%	$	138,336		100.0	%
Cost of revenue		61,987		37.7	%		54,200		39.2	%


Gross profit	$	102,397		62.3	%	$	84,136		60.8	%

Gross profit margins at the NextGen Division for the six months ended September 30, 2010 increased to 69.0% compared to 67.0% for the six months ended September 30, 2009 primarily due to improvements in EDI and hardware margins. Gross profit margins at the QSI Dental Division for the six months ended September 30, 2010 decreased to 53.5% from 55.5% for the six months ended September 30, 2009 primarily as a result of a higher percentage hardware and third party software expense and higher costs for payroll and related benefits in the six months ended September 30, 2010 as compared to the same period a year ago. Gross margin in the Practice Solutions Division decreased to 29.1% for the six months ended September 30, 2010 as compared to 31.5% in the prior year period because the prior year period gross margin was positively impacted by $1.5 million of software license sales as compared to $0.3 million of software sales recorded in the six months ended September 30, 2010.

The following table details the individual components of cost of revenue and gross profit as a percentage of total revenue on a consolidated and divisional basis for the six months ended September 30, 2010 and 2009:


	Hardware,			Payroll and
	Third Party			Related									Total Cost
	Software			Benefits			EDI			Other			of Revenue			Gross Profit
Six months ended September 30, 2010
QSI Dental Division		9.7	%		16.6	%		12.8	%		7.4	%		46.5	%		53.5	%
NextGen Division		3.5	%		12.6	%		8.5	%		6.4	%		31.0	%		69.0	%
Practice Solutions Division		0.0	%		43.8	%		0.0	%		27.1	%		70.9	%		29.1	%


Consolidated		3.4	%		17.4	%		7.5	%		9.4	%		37.7	%		62.3	%


Six months ended September 30, 2009
QSI Dental Division		7.8	%		14.5	%		17.5	%		4.7	%		44.5	%		55.5	%
NextGen Division		3.7	%		12.7	%		10.6	%		6.0	%		33.0	%		67.0	%
Practice Solutions Division		0.1	%		44.4	%		0.0	%		24.0	%		68.5	%		31.5	%


Consolidated		3.4	%		18.4	%		8.7	%		8.7	%		39.2	%		60.8	%

The decrease in our consolidated cost of revenue as a percentage of revenue between the six months ended September 30, 2010 and 2009 is primarily attributable to lower consolidated payroll and related benefits expense and lower EDI costs as a percentage of revenue. Other expense, which primarily consists of third party annual license and hosting costs, increased to 9.4% of total revenue during the six months ended September 30, 2010 as compared to 8.7% for the same period a year ago.

During the six months ended September 30, 2010, hardware and third party software constituted a lower portion of cost of revenue compared to the prior year period in the NextGen Division. The number of customers who purchase hardware and third party software and the dollar amount of hardware and third party software purchased fluctuates each quarter depending on the needs of our customers.

Our payroll and benefits expense associated with delivering our products and services decreased to 17.4% of consolidated revenue in the six months ended September 30, 2010 compared to 18.4% during the same period last year. The absolute level of consolidated payroll and benefit expenses grew from $24.6 million in the six months ended September 30, 2009 to $28.6 million in the six months ended September 30, 2010, an increase of 16.3%, or approximately $4.0 million. Of the $4.0 million increase, approximately $0.9 million of the increase is related to the Practice Solutions Division. RCM is a service business, which inherently has higher percentage of payroll costs as a percentage of revenue. For the NextGen Division, an increase of approximately $2.6 million was related to increased headcount and payroll and benefits expense associated with delivering products and services. Payroll and benefits expense associated with delivering products and services in the QSI Dental Division increased $0.5 million from $1.2 million in the six months ended September 30, 2009 to $1.7 million in the six months ended September 30, 2010.

As a result of the foregoing events and activities, the gross profit percentage for the Company increased for the six months ended September 30, 2010 versus the prior year period.

Selling, General and Administrative Expenses. Selling, general and administrative expenses for the six months ended September 30, 2010 increased 27.2% to $51.1 million as compared to $40.2 million for the prior year period. The increase in these expenses resulted primarily from:

	•		$8.2 million increase in salaries and related benefit expenses primarily as a result of headcount additions;

	•		$2.2 million increase due to a full quarter of selling and administrative expenses from Opus, which was acquired in February 2010;

	•		$0.8 million increase in business integration costs related to consolidating the operations at the Practice Solutions Division;

	•		$0.6 million decrease in advertising and tradeshows, and

	•		$0.3 million net increase in other selling and administrative expenses.

Share-based compensation expense was approximately $1.7 million and $1.3 million for the six months ended September 30, 2010 and 2009, respectively, and is included in the aforementioned amounts. Selling, general and administrative expenses as a percentage of revenue increased from 29.0% in the six months ended September 30, 2009 to 31.1% in the six months ended September 30, 2010.

Research and Development Costs. Research and development costs for the six months ended September 30, 2010 and 2009 were $10.7 million and $8.3 million, respectively. The increases in research and development expenses were due in part to increased investment in the NextGen Division product line. The Opus and Sphere acquisitions added $1.1 million in research and development expenses during the period ended September 30, 2010. Additions to capitalized software costs offset increases in research and development costs. For the six months ended September 30, 2010, $5.7 million was added to capitalized software costs while $2.9 million was capitalized during the six months ended September 30, 2009 as we continue to enhance our software to meet the Meaningful Use definitions under the ARRA. Research and development costs as a percentage of revenue increased to 6.5% in the six months ended September 30, 2010 from 6.0% for the same period in 2009. Research and development expenses are expected to continue at or above current dollar levels. The application of ASC 718 did not have a significant effect to research and development costs in the six months ended September 30, 2010 and 2009.

Interest and Other Income. Interest and other income for the six months ended September 30, 2010 remained consistent at $0.2 million as compared to the six months ended September 30, 2009. Interest and other income consist primarily of dividends and interest earned on our investments.

Provision for Income Taxes. The provision for income taxes for the six months ended September 30, 2010 was approximately $14.6 million as compared to approximately $13.0 million for the corresponding period a year ago. The effective tax rates were 36.4% and 36.9% for the six months ended September 30, 2010 and 2009, respectively. The effective rate for the six months ended September 30, 2010 decreased from the prior year primarily due to fluctuations in the state effective tax rate and increased benefits from the qualified production activities deduction, offset by the expiration of the federal research and development tax credit statute, which occurred at the end of the fourth quarter of fiscal year 2010 and therefore was not included in the provision for the six months ended September 30, 2010.

Liquidity and Capital Resources

The following table presents selected financial statistics and information for the six months ended September 30, 2010 and 2009 (dollar amounts in thousands):


	Six Months Ended September 30,
	2010		2009
Cash and cash equivalents	$	106,852	$	75,429
Net increase in cash and cash equivalents	$	22,241	$	5,249
Net income	$	25,522	$	22,166
Net cash provided by operating activities	$	36,710	$	22,883
Number of days of sales outstanding		126		124

Cash Flows from Operating Activities

Cash provided by operations has historically been our primary source of cash and has primarily been driven by our net income plus adjustments to add back non-cash expenses, including depreciation, amortization of intangibles and capitalized software costs, provisions for bad debts and inventory obsolescence, share-based compensation and deferred taxes.

The following table summarizes our consolidated statements of cash flows for the six months ended September 30, 2010 and 2009 (in thousands):


	Six Months Ended September 30,
	2010			2009
Net income	$	25,522		$	22,166
Non-cash expenses		10,471			7,865
Change in deferred revenue		1,951			1,110
Change in accounts receivable		(7,034	)		(8,816	)
Change in other assets and liabilities		5,800			558

Net cash provided by operating activities	$	36,710		$	22,883

Net Income. As referenced in the above table, net income makes up the majority of our cash generated from operations for the six months ended September 30, 2010 and 2009. The NextGen Division’s contribution to net income has increased each year due to that Division’s operating income increasing more quickly than our Company as a whole.

Non-Cash Expenses. Non-cash expenses include depreciation, amortization of intangibles and capitalized software costs, provisions for bad debts, share-based compensation and deferred taxes. Total non-cash expenses were $10.5 million and $7.9 million for the six months ended September 30, 2010 and 2009, respectively. The $2.6 million increase in non-cash expenses for the six months ended September 30, 2010 as compared to the prior year period is primarily related to an increase of approximately $0.2 million in depreciation, $0.6 million of amortization of capitalized software costs, $0.9 million of amortization of other intangibles, $0.2 million in bad debt expense, $0.5 million in share-based compensation and $0.2 million in deferred income tax benefit.

Deferred Revenue. Cash from operations benefited from increases in deferred revenue. Deferred revenue increased by approximately $2.0 million for the six months ended September 30, 2010 versus an increase of $1.1 million in the prior year period, resulting in a $0.9 million increase to cash from operations as compared to the prior year period.

Accounts Receivable. Accounts receivable grew by approximately $7.0 million and $8.8 million for the six months ended September 30, 2010 and 2009, respectively. The increase in accounts receivable in the periods is due to the following factors:

NextGen Division revenue grew 20.1% and 22.8% on a year-over-year basis, in the six months ended September 30, 2010 and 2009, respectively; and

Turnover of accounts receivable is generally slower in the NextGen Division due to the fact that the systems sales related revenue have longer payment terms, generally up to one year, which historically have accounted for a major portion of NextGen Division sales.

We experienced an increase in the volume of undelivered services billed in advance by the NextGen Division, which were unpaid as of the end of each period and included in accounts receivable. This resulted in an increase in both deferred revenue and accounts receivable of approximately $12.0 million for the six months ended September 30, 2010.

The turnover of accounts receivable measured in terms of days sales outstanding (“DSO”) increased from 124 days to 126 days during the six months ended September 30, 2010. The increase in DSO is primarily due to the factors mentioned above as well as an increase in NextGen Division system sales as compared to the prior year, offset by an increase in recurring revenue, such as maintenance, EDI and RCM revenue, which has a faster turnover of accounts receivable compared to system sales.

If amounts included in both accounts receivable and deferred revenue were netted, our turnover of accounts receivable expressed as DSO would be 81 days as of September 30, 2010 and 88 days as of September 30, 2009. Provided turnover of accounts receivable, deferred revenue, and profitability remain consistent with the six months ended September 30, 2010, we anticipate being able to continue to generate cash from operations during fiscal 2011 primarily from our net income.

Cash Flows from Investing Activities

Net cash used in investing activities for the six months ended September 30, 2010 and 2009 was $0.3 million and $6.3 million, respectively. The decrease of net cash used in investing activities of $6.0 million is primarily the result of $7.7 million in proceeds received from the sale of the ARS investments and a net decrease of $0.8 million in additions to equipment and improvements, offset by a net increase of $2.8 million in additions to capitalized software.

Cash Flows from Financing Activities

Net cash used in financing activities for the six months ended September 30, 2010 and 2009 was $14.2 million and $11.3 million, respectively. During the six months ended September 30, 2010, we received proceeds of $2.8 million from the exercise of stock options and paid $17.3 million in dividends to shareholders as compared to proceeds of $4.7 million from the exercise of stock options and payment of $17.1 million in dividends to shareholders during the same period in the prior year. We recorded a reduction in our tax benefit from share-based compensation of $0.3 million and $1.1 million during the six months ended September 30, 2010 and 2009, respectively, related to excess tax deductions received from stock option exercises. The benefit was recorded as additional paid in capital.

Cash and Cash Equivalents and Marketable Securities

At September 30, 2010, we had cash and cash equivalents of $106.9 million. We intend to expend some of these funds for the development of products complementary to our existing product line as well as new versions of certain of our products. These developments are intended to take advantage of more powerful technologies and to increase the integration of our products. We also intend to make investments in an enterprise system.

In January 2007, our Board of Directors adopted a policy whereby we intend to pay a regular quarterly dividend of $0.25 per share on our outstanding Common Stock, subject to further Board review and approval and establishment of record and distribution dates by our Board of Directors prior to the declaration of each such quarterly dividend. In August 2008, our Board of Directors increased the quarterly dividend to $0.30 per share. We anticipate that future quarterly dividends, if and when declared by our Board of Directors pursuant to this policy, would likely be distributable on or about the fifth day of each of the months of October, January, April and July.

Our Board of Directors declared the following dividends during the periods presented:


			Per Share
Declaration Date	Record Date	Payment Date	Dividend
Fiscal year 2011
May 26, 2010	June 17, 2010	July 6, 2010	$0.30
July 28, 2010	September 17, 2010	October 5, 2010	0.30

Fiscal year 2010
May 27, 2009	June 12, 2009	July 6, 2009	$0.30
July 23, 2009	September 25, 2009	October 5, 2009	0.30
October 28, 2009	December 23, 2009	January 5, 2010	0.30
January 27, 2010	March 23, 2010	April 5, 2010	0.30

Management believes that its cash and cash equivalents on hand at September 30, 2010, together with its marketable securities and cash flows from operations, if any, will be sufficient to meet its working capital and capital expenditure requirements as well as any dividends to be paid in the ordinary course of business for the remainder of fiscal year 2011.

Contractual Obligations

The following table summarizes our significant contractual obligations, all of which relate to operating leases, at September 30, 2010 and the effect that such obligations are expected to have on our liquidity and cash in future periods:


Year ended March 31,
2011 (remaining six months)	$	2,178
2012		4,682
2013		4,907
2014		5,230
2015 and beyond		9,515

	$	26,512

New Accounting Pronouncements

Refer to Note 1 of our Notes to Consolidated Financial Statements, “Summary of Significant Accounting Policies,” included in this Quarterly Report on Form 10-Q for a discussion of new accounting standards.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

We currently maintain our cash in very liquid short term assets including tax exempt and taxable money market funds and short-term U.S. Treasury securities with original maturities of less than 90 days.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security Exchange Act of 1934, as amended) as of September 30, 2010, the end of the period covered by the Quarterly Report (the “Evaluation Date”). They have concluded that, as of the Evaluation Date, these disclosure controls and procedures were effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities and would be disclosed on a timely basis. The Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are designed, and are effective, to give reasonable assurance that the information required to be disclosed by the Company in reports that it files under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the rules and forms of the SEC. They have also concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

During the quarter ended September 30, 2010, there were no changes in our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

The Company’s management, including its Chief Executive Officer and Chief Financial Officer, has concluded that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at that reasonable assurance level. However, the Company’s management can provide no assurance that our disclosure controls and procedures or our internal control over financial reporting can prevent all errors and all fraud under all circumstances. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been or will be detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We have experienced legal claims by parties asserting that we have infringed their intellectual property rights. We believe that these claims are without merit and intend to defend against them vigorously; however, we could incur substantial costs and diversion of management resources defending any infringement claim — even if we are ultimately successful in the defense of such matter. Litigation is inherently uncertain and always difficult to predict. We refer you to the discussion of infringement and litigation risks in our Risk Factors section of our Annual Report on Form 10-K.

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors disclosed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. (REMOVED AND RESERVED)

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS


Exhibit
Number		Description

31.1	*	Certification of Principal Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	*	Certification of Principal Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	*	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

10.1	*	First Amendment to Office Lease, dated July 8, 2010, between the Company and Lakeshore Towers Limited Partnership Phase II.

101.INS	**	XBRL Instance

101.SCH	**	XBRL Taxonomy Extension Schema

101.CAL	**	XBRL Taxonomy Extension Calculation

101.LAB	**	XBRL Taxonomy Extension Label

101.PRE	**	XBRL Taxonomy Extension Presentation


*		Filed herewith.

**		XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of section 11 or 12 of the Securities and Exchange Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these section.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

QUALITY SYSTEMS, INC.



Date: November 3, 2010	By:	/s/ Steven T. Plochocki
		Steven T. Plochocki
		Chief Executive Officer (Principal Executive Officer)


Date: November 3, 2010	By:	/s/ Paul A. Holt
		Paul A. Holt
		Chief Financial Officer (Principal Accounting Officer)